multipl
sclerosi
ms
diseas
affect
matur
central
nervou
system
cn
one
lesion
found
dissemin
time
space
frequent
success
relaps
period
remiss
individu
patient
cours
diseas
remarkedli
variabl
age
onset
neurolog
symptom
rang
year
maximum
incid
year
age
ms
attack
women
frequent
men
women
affect
slightli
earlier
damag
larg
restrict
white
matter
cn
lesion
consist
fibrou
plaqu
demyelin
nerv
tract
axon
frequent
spare
plaqu
tend
distribut
site
prefer
exampl
frequent
follow
contour
third
fourth
ventricl
zonal
plaqu
may
locat
immedi
beneath
pia
matter
particularli
sulci
cerebr
hemispher
plaqu
particularli
cortex
may
subclin
silent
becom
appar
post
mortem
emi
scan
anoth
site
predilect
opti
nerv
clinic
sign
relat
close
demyelin
nerv
plaqu
demyelin
brain
stem
spinal
cord
also
associ
local
sign
eg
paraplegia
incontin
epidemiolog
ms
uniformli
distribut
world
incid
much
greater
temper
zone
roughli
north
south
equat
subtrop
tropic
zone
low
risk
area
less
per
south
erica
africa
area
northern
unit
state
europ
incid
high
ho
per
also
centr
even
higher
concentr
exampl
per
orkney
shetland
isl
sever
studi
focus
incid
ms
immigr
popul
move
high
low
risk
area
vice
versa
migrant
appear
carri
high
risk
countri
origin
emigr
age
year
likewis
immigr
unit
kingdom
asia
africa
low
risk
area
greatli
reduc
chanc
develop
ms
dean
point
epidemiolog
ms
resembl
paralyt
poliomyel
viral
infect
also
common
countri
high
standard
hygien
epidemiolog
find
ms
consist
exposur
environment
factor
late
childhood
preced
onset
symptom
altern
factor
eg
viru
may
restrict
temper
zone
acquir
slow
viru
childhood
clinic
ms
notori
difficult
diagnos
earli
stage
diseas
utterli
unpredict
cours
patient
afflict
sever
rapidli
progress
form
diseas
may
die
secondari
effect
within
year
howev
major
suffer
vari
degre
motor
sensori
disabl
cours
altern
exacerb
relaps
remiss
individu
may
suffer
rel
sever
attack
subsid
within
week
day
appar
free
symptom
month
year
anoth
disabl
attack
superven
although
aetiolog
ms
unknown
diseas
appar
exacerb
stress
intercurr
infect
degre
chang
state
patient
attribut
function
chang
preexist
lesion
make
clinic
assess
patient
difficult
symptom
may
even
intensifi
increas
bodi
temperatur
eg
hot
bath
thu
relaps
must
identifi
distinct
new
sign
due
reemerg
older
lesion
rapid
chang
sign
symptom
due
entir
demyelin
remyelin
adult
cn
capabl
limit
myelin
synthesi
one
revers
factor
may
oedema
myelin
sheath
consid
earli
patholog
event
temporari
action
synapt
block
factor
present
sera
ms
patient
estim
time
diagnosi
life
expect
normal
alreadi
indic
estim
true
patient
variabl
cours
extent
diseas
led
suggest
ms
singl
clinic
entiti
rather
spectrum
extend
malign
progress
condit
rel
benign
form
happen
case
optic
neuriti
appreci
criteria
adopt
diagnosi
classif
evalu
clinic
statu
ms
patient
critic
import
medic
research
diseas
scheme
classif
ms
case
shown
tabl
accord
strict
criteria
progress
case
kept
separ
pathogenesi
may
differ
form
ms
may
difficult
differenti
famili
spastic
paraplegia
although
patient
optic
neuiti
eventu
develop
ms
individu
patient
sure
prognosi
although
case
histori
may
suggest
ms
diagnost
variou
test
avail
help
neurologist
use
visual
evok
potenti
respons
chang
wave
form
may
detect
ms
patient
abnorm
auditori
evok
potenti
also
record
proport
patient
respons
pattern
complex
difficult
interpret
visual
evok
respons
increas
valu
examin
electrophoret
separ
cerebrospin
fluid
csf
protein
oligoclon
band
igg
region
see
chapter
found
mani
ms
patient
test
involv
lymphocyt
macrophag
function
respons
antigen
eg
myelin
basic
protein
simplifi
erythrocyt
mobil
tst
presenc
linol
acid
controversi
establish
procedur
occurr
signific
cluster
ms
case
slightli
increas
famili
incid
suggest
influenc
inherit
factor
possibl
common
exposur
infect
agent
thu
exampl
millar
found
increas
incid
ms
irish
agricultur
worker
result
famili
studi
number
countri
suggest
proport
affect
first
degre
live
rel
ms
patient
time
expect
frequenc
diseas
occur
follow
order
sibl
parent
children
rel
low
rate
concord
monozygot
twin
show
simpl
genet
explan
ms
applic
remit
relaps
histori
two
episod
evid
white
matter
lesion
two
separ
site
cn
age
onset
year
clinic
histori
sign
symptom
one
year
longer
may
exampl
histori
acut
retrobulbar
neuriti
paraesthesia
motor
weak
doubl
vision
unsteadi
symptom
known
occur
ms
follow
one
relaps
gradual
onset
paraplegia
may
follow
relaps
sign
indic
diseas
brainstem
cerebrum
optic
nerv
probabl
origin
clinic
evid
multipl
lesion
suggest
ms
follow
good
recoveri
histori
one
attack
acut
retrobulbar
neuriti
accompani
follow
pyramid
sign
usual
mild
degre
subsequ
relaps
possibl
probabl
unusu
featur
sign
progress
histori
paraplegia
usual
earli
middl
age
optic
neuriti
recurr
retrobulbar
neuriti
without
featur
ms
exclud
mcalpin
cowork
mcdonald
halliday
howev
good
although
indirect
evid
genet
compon
associ
suscept
ms
found
singl
immunogenet
complex
determin
strong
transplant
antigen
particular
speci
known
major
histocompatibi
complex
mhc
first
han
antigen
detect
leucocyt
therefor
known
human
leucocyt
antigen
hla
detect
hla
initi
depend
avail
agglutin
antisera
later
reliabl
conveni
lymphocytotox
test
develop
ii
lymphocyt
differ
individu
cultur
togeth
cell
interact
transform
blast
cell
reaction
known
mix
lymphocyt
cultur
mlc
also
found
primarili
control
mhc
gene
mhc
antigen
code
gene
occur
four
site
loci
chromosom
antigen
detect
lymphocytotox
test
peripher
blood
leucocyt
code
hla
b
c
locu
antigen
detect
mlc
code
hlad
locu
gene
known
ir
gene
alsound
chromosom
region
yet
directli
identifi
vitro
techniqu
relat
though
probabl
ident
class
hla
serolog
detect
mainli
found
peripher
blood
b
lymphocyt
mous
serolog
defin
antigen
known
immun
respons
associ
la
antigen
human
close
relat
hlad
antigen
known
hlad
relat
hladr
antigen
exact
relationship
ir
la
hlad
hladr
clear
mani
human
diseas
found
associ
hla
antigen
hla
b
c
dr
class
probabl
one
mechan
involv
associ
mani
thought
due
associ
immun
respons
gene
therefor
closest
associ
found
hlad
dr
antigen
associ
hlaa
b
antigen
probabl
secondari
two
diseas
nervou
system
studi
detail
tabl
myasthenia
gravi
shown
associ
w
indic
assign
antigen
still
provision
associ
strongest
young
femal
patient
without
thymoma
strong
older
patient
patient
thymoma
suggest
one
pathogen
mechan
involv
develop
myasthenia
gravi
n
shown
associ
closest
associ
equival
local
defin
antigen
mechan
presenc
antigen
lead
suscept
ms
known
genet
determin
immunolog
respons
environment
agent
probabl
way
respons
simpl
hypothesi
complic
find
equal
strong
differ
associ
found
arab
patient
ms
indic
either
differ
environment
agent
involv
develop
diseas
differ
part
world
yet
unidentifi
mhc
gene
respons
suscept
ms
method
clinic
evaluatiom
ms
patient
improv
allow
classif
case
neurophysiolog
techniqu
discoveri
oligoclon
band
antibodi
csf
particular
valu
classif
invalu
studi
inherit
immunogenet
factor
patient
ms
shown
associ
certain
kind
hla
antigen
differ
associ
found
differ
race
unidentifi
mhc
gene
probabl
respons
suscept
ms
gene
locu
may
associ
immun
respons
gene
chapter
myelin
sheath
consist
lipoprotein
lamella
encircl
axon
thu
myelin
particularli
concentr
area
compos
mainli
fibr
tract
ie
brain
white
matter
spinal
cord
account
dri
weight
myelin
nervou
system
proce
caudocrani
sequenc
pathway
becom
myelin
phylogenet
order
lile
myelin
tract
human
central
nervou
system
cn
taken
place
two
year
age
histolog
studi
show
fulli
matur
myelin
sheath
found
end
second
decad
period
maximum
rate
myelin
follow
period
cellular
prolifer
differ
tempor
relationship
birth
differ
speci
man
maximum
rate
myelin
cortex
occur
birth
myelin
elabor
oligodendrogli
cell
earli
stage
connect
seen
tongu
cytoplasm
outsid
myelin
sheath
process
come
cell
oligodendrocyt
form
maintain
myelin
segment
myelin
structur
rel
low
water
content
purifi
fraction
human
brain
contain
dri
weight
lipid
uniqu
chemic
properti
facilit
readi
isol
myelin
high
puriti
use
convent
densiti
centrifug
techniqu
small
variat
myelin
composit
differ
speci
differ
area
cn
membran
lipid
molar
ratio
cholesterol
phospholipid
galactolipid
vari
tabl
cholesterol
abund
lipid
myelin
sterol
present
cellular
membran
although
exclus
myelin
characterist
lipid
galactolipid
cerebrosid
concentr
directli
proprot
amount
myelin
brain
anoth
characterist
marker
myelin
ethanolamin
plasmalogen
ethanolamin
phospholipid
vinyl
form
almost
exclus
locat
white
matter
small
amount
polyphosphosinositid
gangliosid
also
present
myelin
monosialogangliosid
gmi
account
mole
myelin
gangliosid
rat
unusu
gangliosid
sialosylgalactosylceramid
g
major
compon
human
myelin
gangliosid
ii
protein
composit
cn
myelin
uniqu
simpl
two
major
constitu
basic
protein
bp
proteolipid
protein
plp
make
total
protein
fig
bp
account
approxim
total
protein
myelin
sheath
calcul
molecular
weight
dalton
depend
speci
isol
bp
contain
approxim
amino
acid
residu
isoelectr
point
greater
ph
aqueou
solut
axial
ratio
prolat
ellipsoid
ieo
braun
brostoff
biolog
properti
basic
protein
well
establish
myelin
bp
purifi
brain
spinal
cord
numer
speci
induc
experiment
allerg
encephalomyel
eae
laboratori
anim
see
chapter
h
primari
demyelin
diseas
ich
result
delay
hypersensit
reaction
whole
bp
encephalitogen
fragment
deriv
bp
bp
suscept
rapid
extens
digest
trypsin
chymotrypsin
pepsin
pronas
hydrolysi
enzym
brain
phagocyt
cell
select
mixtur
encephalitogen
nonencephalitogen
peptid
produc
brain
cathepsin
special
affin
peptid
bond
two
pheph
sequenc
molecul
three
peptid
appear
releas
maerophag
acid
proteinas
fig
bp
also
highli
suscept
digest
neutral
proteinas
polymorphonuclear
pmn
cell
thu
enzym
endogen
brain
tissu
may
play
ratelimit
role
bp
breakdown
relaps
fragment
cell
immun
systemmay
import
regul
immun
respons
autoimmun
diseas
addit
diseas
induct
bp
give
rise
specif
circul
antibodi
lipidfre
protein
readili
solubl
aqueou
media
requir
deterg
solubil
howev
readili
succinyl
give
molecul
solubl
wide
rang
aqueou
condit
analys
sdsprotein
complex
polyacrylamid
gel
electrophoresi
page
establish
molecular
weight
major
compon
minor
compon
protein
prepar
column
procedur
major
glutam
aspart
residu
present
amid
would
result
net
basic
charg
molecul
amino
acid
composit
plp
differ
speci
well
document
work
sequenc
incomplet
inform
exact
molecular
shape
plp
lack
organ
solvent
protein
high
helic
content
take
molecular
weight
apoprotein
dalton
plp
spheric
form
calcul
diamet
free
sulphydryl
group
appear
contribut
stabil
secondari
tertiari
structur
plp
nativ
protein
protect
oxid
anion
phospholipid
hydrophob
natur
plp
rel
resist
proteolysi
presenc
nonion
deterg
triton
expect
digest
trypsin
take
place
oxid
crude
proteolipid
suscept
tryptic
digest
unoxid
prepar
apoprotein
oxid
proteolipid
digest
thermolysin
echymotrypsin
prepar
attack
elastas
high
molecular
weight
protein
total
protein
myelin
separ
sdspage
high
molecular
weight
compon
resolv
doublet
seen
molecular
weight
rang
protein
fraction
refer
wolfgram
fraction
wp
high
molecular
weight
protein
fraction
compris
larg
part
total
myelin
protein
immatur
brain
brain
matur
pattern
chang
amount
basic
proteolipid
protein
show
rel
increas
small
amount
glycoprotein
consist
found
isol
myelin
accumul
concurr
myelin
format
applic
lactoperoxidas
iodin
galactos
oxidas
label
immunochem
techniqu
use
chemic
probe
result
model
highmolecular
weight
protein
intrapefiod
line
extern
nacai
argch
lipidprotein
interact
unit
myelin
structur
molecular
organis
myelin
compon
myelin
appear
asymmetr
distribut
membran
lipid
phase
myelin
bilay
arrang
intermedi
fluid
state
best
fit
data
action
galactos
oxidas
point
local
cerebrosid
sulphatid
extern
membran
surfac
local
phospholipid
cholesterol
gangliosid
yet
determin
high
molecular
weight
protein
consid
intrins
compon
locat
extern
membran
surfac
part
polypeptid
chain
lipid
phase
plp
also
intrins
may
complet
embed
lipid
phase
bp
extrins
compon
local
surfac
lipid
phase
cytoplasm
membran
surfac
fig
compar
brain
structur
myelin
rel
metabol
stabl
low
enzym
activ
two
characterist
enzym
compon
myelin
first
nucleotid
use
myelin
marker
total
activ
present
myelin
high
level
also
found
oligodendrogli
cell
physiolog
function
yet
assign
enzym
second
myelinspecif
enzym
cholesterol
ester
hydrolas
ph
optimum
may
play
role
control
brain
cholesterol
ester
level
develop
protein
kinas
capabl
phosphoryl
basic
protein
neutral
proteinas
locat
myelin
yet
physiolog
function
attribut
either
myelin
activ
number
enzym
concern
biosynthesi
myelin
lipid
increas
direct
proport
rate
myelin
deposit
specif
activ
enzym
respons
synthesi
cholesterol
phospholipid
galactolipid
found
highest
microsom
fraction
peak
activ
cerebrosid
synthetas
mous
microsom
either
hydroxi
nonhydroxi
fatti
acid
preced
maxim
rate
myelin
accumul
day
morpholog
matur
oligodendroglia
organ
cultur
accompani
increas
sulphatid
synthesi
isol
oligodendrocyt
enrich
number
galactolipidsynthes
enzym
enzym
involv
cholesterol
biosynthesi
increas
activ
myelin
decreas
pattern
fotuld
synthesi
two
phospholipid
enrich
myelin
triphosphoinositid
ethanolamin
plasmalogen
pulsechas
experi
specif
radioact
compon
propos
precursor
membran
drop
dramat
indic
transport
sulphatid
microsom
myelin
may
affect
solubl
lipoprotein
differ
rout
transport
propos
phosphatidyl
cholin
specif
radioact
lipid
supernat
alway
greater
microsom
phosphatidylinositol
phosphatidyl
cholin
transfer
activ
solubl
protein
fraction
prepar
synaptosom
myelin
fraction
found
increas
sevenand
threefold
respect
compar
whole
brain
synthet
site
transport
mechan
myelin
protein
determin
intracrani
inject
label
amino
acid
benjamin
cowork
found
appear
radioact
myelin
protein
show
lag
rel
total
brain
protein
vivo
slice
high
molecular
weight
protein
includ
wolfgram
protein
incorpor
radioact
faster
rate
basic
proteolipid
protein
chemic
composit
myelin
chang
age
anim
rat
matur
myelin
galactolipid
increas
phosphatidyl
cholin
decreas
similar
amount
immatur
brain
high
molecular
weight
protein
make
major
total
brain
matur
rel
concentr
high
molecular
weight
protein
decreas
amount
basic
proteolipid
protein
show
increas
also
evid
accumul
bp
preced
plp
propos
myelin
first
laid
oligodendrogli
cell
composit
may
close
glial
cell
membran
differ
myelin
composit
immatur
brain
found
result
cosepar
myelinlik
fraction
unpurifi
myelin
centrifug
procedur
themyelinlikelfract
account
much
crude
myelin
rat
much
smaller
amount
adult
evid
fraction
relat
myelin
somewhat
inconclus
review
recent
norton
sinc
myelin
sheath
contain
mani
tightlypack
lipoprotein
membran
tenuou
link
matur
oligodendrocyt
alway
difficult
consid
structur
dynam
one
myelin
appear
restrict
adult
cn
deposit
myelin
ceas
concept
support
find
littl
enzym
activ
within
myelin
sheath
experiment
studi
turnov
myelin
appear
exceedingli
slow
exampl
substanti
amount
label
cholesterol
incorpor
cn
rabbit
chicken
develop
evid
molecul
remain
year
white
matter
disappear
within
month
organ
well
grey
matter
similar
result
obtain
precursor
littl
loss
radioact
label
compon
measur
whole
brain
isol
myelin
long
interv
suggest
myelin
stabl
metabol
unit
adult
rat
brain
myelin
account
total
radioact
day
inject
increas
day
absolut
amount
remain
unchang
throughout
experi
half
life
myelin
fraction
found
day
common
long
term
experi
myelin
rat
least
remain
total
brain
lipid
radioact
present
myelin
fraction
month
result
emphas
higher
turnov
rate
fraction
myelin
fact
radioact
taken
lipid
adult
myelin
indic
small
fraction
adult
myelin
undergo
rapid
metabol
rest
myelin
lipid
rel
stabl
evid
concept
myelin
sheath
uniform
metabol
entiti
came
number
laboratori
particular
smith
inject
adult
rat
e
found
signific
radioact
myelin
fraction
underw
slow
turnov
inositol
phosphatid
lecithin
show
faster
turnov
serin
phosphatid
ethanolamin
phosphatid
turn
metabol
quickli
sphingomyelin
cholesterol
galactolipid
cerebrosid
sulphatid
nevertheless
rel
term
metabol
activ
myelin
low
label
polyphosphoinositid
phosphat
isol
pure
myelin
found
great
whole
brain
although
littl
synthesi
remain
myelin
phospholipid
occur
long
term
studi
myelin
protein
young
adult
anim
long
short
halfliv
individu
protein
found
studi
indic
portion
basic
proteolipid
protein
myelin
essenti
stabl
high
molecular
weight
protein
halfliv
month
rate
myelin
metabol
reflect
balanc
net
addit
exchang
molecul
membran
result
sophn
davison
young
adult
anim
vivo
show
uptak
radioact
cholesterol
subcellular
fraction
ultim
uniform
distribut
label
lipid
studi
cholesterol
synthesi
inhibitor
show
unexpect
rapid
disappear
sterol
precursor
incorpor
develop
myelin
sheath
discontinu
drug
treatment
loss
incorpor
precursor
myelin
effect
exchang
process
convers
cholesterol
within
membran
vitro
studi
also
provid
evid
exchang
myelin
subcellular
fraction
prelabel
microsom
fraction
incub
unlabel
whole
brain
homogen
transfer
cholesterol
phospholipid
cerebrosid
radioact
respect
myelin
fraction
revers
experi
label
lipid
class
recov
microsom
miller
dawson
demonstr
transfer
phospholipid
certain
condit
myelin
found
inhibit
complet
transfer
reaction
myelin
multilam
lar
membran
whose
composit
well
establish
dri
weight
lipid
cholesterol
phospholipid
cerebrosid
domin
compon
three
major
protein
constitu
myelin
basic
protein
interest
myelin
constitu
remark
metabol
stabl
compon
undergo
turnov
myelin
lipid
undergo
exchang
molecul
cytoplasm
good
evid
oligodendrogli
cell
respons
synthesi
myelin
integr
adult
myelin
sheath
thu
depend
continu
activ
sustain
glial
cell
activ
myelin
postnat
two
year
period
man
decreas
slowli
young
adult
probabl
littl
synthesi
myelin
compon
may
explain
age
onset
ms
usual
occur
time
activ
myelin
abil
repair
denud
axon
ceas
brenkert
ns
radin
synthesi
galactocerebrosid
glucocerebrosid
rat
brain
assay
procedur
chang
age
brain
re
se
poduslo
wt
norton
isol
chemic
properti
oligodendroglia
calf
brain
j
neurochem
although
aetiolog
multipl
sclerosi
ms
unknown
evid
inherit
genet
factor
coupl
nonspecif
viru
infect
autoimmun
respons
myelin
glial
antigen
satisfactori
anim
model
fulfil
criteria
extens
experiment
investig
demyelin
precipit
one
caus
factor
wide
studi
anim
model
demyelin
experiment
allerg
encephalomyel
eae
numer
featur
common
ms
autoimmun
diseas
induc
myelin
basic
protein
see
chapter
sequenc
event
follow
nerv
section
action
neurotox
agent
give
indic
process
demyelin
experiment
anim
model
wallerian
degener
peripher
nerv
section
part
isol
nerv
cell
bodi
undergo
degener
consequ
axon
degener
secondari
demyelin
biochem
find
reflect
wide
varieti
demyelin
condit
ie
reduct
yelin
protein
major
myelin
lipid
cholesterol
cerebrosid
sulphatid
ethanolamin
plasmalogen
increas
cholesterol
ester
cholesterol
ester
accumul
conjunct
rais
lysosom
hydrolas
activ
indic
activ
phagocytosi
myelin
demyelin
tissu
contain
cholesterol
ester
fraction
densiti
gradient
centrifug
fraction
lighter
densiti
myelin
float
top
sucros
fraction
enrich
cholesterol
ester
higher
lipid
protein
ratio
myelin
time
cours
wallerian
degener
much
slower
central
cn
peripher
nervou
system
pn
littl
evid
cell
infiltr
circul
earli
stage
section
although
yield
myelin
degener
rat
optic
nerv
decreas
isol
myelin
appear
morpholog
chemic
normal
apart
slight
increas
cholesterol
concentr
slight
decreas
amount
ethanolamin
glycerophosphatid
nonspecif
lipid
find
seen
demyelin
condit
preferenti
breakdown
myelin
protein
constitu
occur
find
normal
protein
lipid
composit
myelin
isol
r
optic
nerv
day
enucl
consist
morlolog
evid
myelin
broken
engulf
macrophag
evid
glial
cell
also
particip
phagocytosi
degener
axon
myelin
sheath
demyelin
experiment
condit
independ
inflammatori
cell
chronic
administr
triethyltin
rat
produc
oedema
cn
sever
paralysi
myelin
recoveri
reduc
accompani
increas
level
cholesterol
ester
absenc
phagocyt
cell
cn
consist
lack
cholesterol
ester
format
float
fraction
observ
myelin
purifi
oedemat
brain
triethyltin
treat
anim
apart
reduct
total
protein
content
chemic
composit
differ
myelin
diphtheria
toxin
direct
microinject
diphtheria
toxin
spinal
cord
optic
chiasma
produc
focal
lesion
show
microscop
sever
myelin
destruct
axon
preserv
wallerian
degener
toward
middl
lesion
toxin
neurotox
demyelin
occur
first
appear
phagocyt
cell
heat
denatur
toxin
innocu
later
stage
oedemat
lesion
resembl
histolog
acut
ms
lesion
destruct
myelin
preserv
axon
continu
cellular
reaction
phagocytosi
myelin
debri
contrast
situat
eae
littl
penetr
sheath
strip
myelin
cell
remyelin
spinal
cord
optic
chiasma
oligodendrocyt
appar
inject
toxin
conduct
complet
block
larg
lesion
slow
smaller
lesion
littl
biochem
investig
lesion
cn
pn
pattern
demyelin
similar
effect
diphtheria
toxin
investig
vitro
detect
degrad
myelin
protein
sulphatid
sciatic
nerv
chick
embroyo
found
incub
diphtheria
toxin
vitro
hour
instead
toxin
inhibit
vitro
incorpor
radioact
label
leucin
pn
myelin
protein
hour
result
inhibit
synthesi
turnov
rate
compon
cn
myelin
much
slow
account
immedi
focal
demyelin
spinal
optic
tract
lesion
caus
factor
must
appli
cn
number
experiment
diseas
exist
viral
aetiolog
demyelin
phase
eventu
result
attack
neuron
axon
element
canin
distemp
result
inject
paramyxoviru
close
relat
measl
best
character
model
group
two
type
lesion
seen
histolog
demyelin
destruct
higher
incid
latter
process
demyelin
associ
macrophag
presenc
viru
enzym
chang
demyelin
lesion
increas
bglucuronidas
acid
proteinas
activ
parallel
macrophag
accumul
lymphocyt
exclud
signific
sourc
increas
enzym
activ
tissu
lymphocyt
enzym
activ
similar
tissu
mani
lymphocyt
find
plasmalogenas
activ
highest
control
tissu
least
sever
demyelin
consid
indic
action
earli
process
demyelin
studi
acut
encephalopathi
result
measl
sindbi
seiki
forest
viru
infect
bowen
cowork
also
found
bglucuronidas
actiivti
appear
particularli
sensit
index
glial
phagocyt
cell
reactiv
anoth
paramyxoviru
design
viru
isol
cultur
brain
cell
ms
patient
induc
immunolog
mediat
degener
corpu
callosum
paraventricular
white
matter
mice
adult
mous
brain
lesion
induc
viru
appear
follow
sequenc
perivascular
cuf
lymphocyt
histiocyt
follow
parenchym
tissu
degener
vari
faint
stain
myelin
total
necrosi
neural
element
ii
anim
model
viralinduc
demyelin
axonspar
featur
infect
mice
avirul
semiiki
forest
viru
also
produc
mild
form
typic
viru
enceph
histolog
usual
featur
perivascular
infiltr
astrocyt
hypertrophi
focal
spongiform
vacuol
accompani
cereoellar
white
matter
demyelin
increas
activ
lysosom
enzym
acid
proteinas
nacetylbdglucosand
galaetosaminidas
glucuronidas
occur
simultan
perivascular
cuf
reduct
brain
viru
titr
increas
serum
antibodi
level
thu
combin
viral
infect
immun
mechan
respons
viral
clearanc
brain
may
induc
biochem
chang
lead
demyelin
tabl
search
viral
particl
post
mortem
brain
ms
patient
fail
provid
evid
support
hypothesi
viral
infect
ms
addit
transfer
diseas
ms
brain
materi
met
minim
success
context
experiment
spongiform
encephalopathi
scrapi
interest
chronic
noninflammatori
nondemyelin
degen
diseas
scrapi
prototyp
slow
viru
infect
nervou
system
despit
extens
electron
microscop
investig
evid
specif
viral
structur
brain
remark
characterist
scrapi
agent
insensit
heat
formalin
uv
ioniz
radiat
result
model
agent
devoid
nucleic
acid
imposs
separ
scrapi
membran
compon
suggest
agent
portion
aberr
membran
upon
infect
caus
cell
produc
piec
membran
contain
error
lack
demonstr
immun
respons
scrapi
circul
antibodi
present
immunosuppress
effect
cours
diseas
scrapi
inocul
caus
rapid
decreas
percentag
polymorphonuclear
neutrohil
pmn
peripher
blood
mice
pmn
factor
similar
separ
scrapi
agent
possibl
link
ms
scrapi
indic
report
level
circul
pmn
cell
mice
depress
inocul
supernat
fraction
msaa
ms
brain
although
cellular
infiltr
scrapieinfect
brain
signific
enzym
chang
occur
lysosom
enzym
chang
fall
two
group
number
enzym
found
increas
week
intracerebr
inocul
includ
bglucuronidas
acid
deoxyribonucleas
nacetyl
galactosaminidas
late
diseas
clinic
phase
acid
proteinas
acid
ribonucleas
bgalactosidas
increas
enzym
chang
consid
secondari
cuprizon
treatment
similar
histopatholog
pictur
scrapi
produc
pattern
enzym
chang
slow
viru
infect
neuropatholog
featur
close
relat
ms
visna
visna
chronic
inflammatori
demyelin
diseas
cn
lesion
character
inflamm
mening
white
matter
associ
demyelin
rel
spare
axon
two
anim
model
demyelin
complic
featur
particular
interest
viru
enter
nervou
system
initi
diseas
reticuloendotheli
system
mous
hepat
viru
enceph
jhm
strain
featur
progress
multifoc
leucoencephalopathi
pml
rare
human
demyelin
condit
occur
individu
chronic
diseas
reticuloendotheli
system
receiv
immunosuppress
therapi
mice
nonspecif
demyelin
relat
mononuclear
cell
take
place
presenc
viru
loss
result
specif
infect
inflamm
increas
cholesterol
ester
detect
consist
absenc
phagocyt
cell
myelin
loss
occur
absenc
inflammatori
cell
demonstr
experiment
white
matter
anim
administ
chronic
triethyltin
marek
diseas
chicken
result
herp
viru
infect
lymph
system
invas
pn
inflammatori
cell
destroy
myelin
manner
eae
cn
secondari
complic
diseas
studi
anim
model
demyelin
viral
infect
evid
mani
featur
common
ms
case
direct
link
found
basi
anim
model
demyelin
appear
proteolyt
lipolyt
enzym
product
common
mediat
myelin
breakdown
reason
detail
investig
action
agent
intact
nervou
tissu
isol
myelin
constitu
lipid
protein
molecular
mechan
tempor
event
demyelin
sequenc
studi
intact
nerv
action
phospholipas
lysolecithin
intact
nervou
tissu
investig
pn
hall
gregson
cn
blakemor
cowork
trypsin
also
found
exert
activ
intact
sciatic
nerv
inject
lipolyt
agent
perineurium
sciatic
nerv
vivo
result
demyelin
within
min
spread
along
incisur
paranod
channel
myelin
sheath
disappear
lesion
hour
replac
debrisfil
cell
resembl
macrophag
phospholipas
produc
ident
effect
demonstr
ultrastructurallv
progress
disrupt
remov
lamellar
sheath
inject
lysolecithin
spinal
cord
produc
similar
lesion
cn
lamellar
split
expans
myelin
structur
also
seen
lysolecithin
ad
cn
myelin
vitro
produc
addit
approxim
half
amount
lysolecithin
requir
solubil
velin
complet
appear
correl
loss
basic
protein
epinur
perineur
sheath
split
allow
penetr
intact
sciatic
nerv
trypsin
major
dens
line
split
lamella
intraperiod
line
separ
hour
digest
wv
trypsin
appropri
control
basic
protein
pi
found
detect
major
myelin
protein
po
glycoprotein
extrem
insolubl
aqueou
solut
complet
digest
purifi
activ
crude
crotalu
atrox
venom
ospholipas
purifi
venom
myelin
investig
cole
cowork
freezedri
myelin
suspend
buffer
sonic
constitu
phospholipid
extens
hydrolyz
crude
venom
purifi
enzym
rate
hydrolysi
lecithin
ethanolamin
phosphoglycerid
similar
somewhat
lower
rate
hydrolysi
acid
serin
phospholipid
product
reaction
found
associ
myelin
condit
rate
hydrolysi
phosphoglycerid
myelin
slower
pure
phosphoglycerid
aqueou
medium
high
concentr
enzym
requir
degrad
substrat
myelin
publish
experi
basic
protein
bp
isol
myelin
report
suscept
digest
trypsin
main
myelin
prepar
watershock
studi
banik
davison
trypsin
show
loss
lipid
bp
myelin
alter
ultrastructur
myelin
sheath
cooper
action
phospholipas
presenc
trypsin
result
extens
loss
bp
proteolipid
protein
plp
convers
myelin
phosphoglycerid
correspond
lysocompound
split
myelin
lamella
observ
electron
micrograph
hand
schafer
franklin
modifi
fraction
method
design
minim
membran
damag
found
bp
intact
myelin
lipoprotein
phase
sulphatid
hydrolyz
trypsin
chymotrypsin
saito
cowork
london
vossenberg
demonstr
acid
lipid
protect
myelin
bp
region
amino
acid
residu
hydrolysi
trypsin
furthermor
bp
intact
brain
strike
contrast
isol
myelin
shield
antibodi
situ
degrad
bp
occur
even
stringent
prepar
procedur
emphas
suscept
action
endogen
enzym
three
fragment
found
gener
bp
action
purifi
bovin
brain
acid
proteinas
analysi
fragment
show
action
enzym
restrict
two
pheph
linkag
posit
protein
isol
fragment
retain
abil
induc
eae
guinea
pig
rabbit
incub
brain
extract
neutral
ph
minim
digest
purifi
bp
take
place
acut
lesion
eae
level
activ
neutral
acid
proteinas
sever
fold
higher
control
brain
cathepsin
show
mark
increas
evid
point
macrophag
marker
enzym
purifi
cathepsin
fail
attack
myelin
bp
act
synergist
catheosin
degrad
one
polypeptid
fragment
bp
isol
myelin
incub
presenc
solubl
extract
brain
ph
roytta
cowork
found
profus
breakdown
bp
loss
plp
incub
neutral
ph
result
breakdown
mark
cowork
show
incub
myelin
hour
purifi
brain
cathepsin
result
loss
bp
loss
plp
condit
incub
myelin
physiolog
ph
also
result
endogen
breakdown
approxim
bp
purifi
myelin
bp
found
excel
substrat
proteolyt
enzym
also
protein
kinas
associ
myelin
fraction
vaccinia
viru
also
contain
protein
kinas
locat
within
viral
core
tenfold
increas
observ
vitro
ad
myelin
bp
compar
core
alon
shown
repres
phosphoryl
bp
vaccinia
viru
induc
demyelin
suggest
direct
viral
action
membran
may
one
mechan
action
enzym
reactiv
rang
bp
relev
phosphoryl
myelin
bp
vaccinia
viru
protein
kinas
demyelin
remain
determin
result
demonstr
lysosom
enzym
endogen
brain
tissu
may
play
role
regul
immun
reaction
well
control
gener
metabol
balanc
phagocyt
cell
immun
system
particular
suppli
batteri
lysosom
enzym
activ
tabl
isol
myelin
purifi
bp
incub
activ
periton
macrophag
homogen
acid
ph
bp
preferenti
broken
three
high
molecular
weight
peptid
produc
fig
least
tenfold
greater
digest
physiolog
ph
hturan
pmn
guinea
pig
periton
macrophag
myelin
appear
vulner
attack
least
two
neutral
proteolyt
activ
secret
macrophag
plasminogendepend
plasminogenindepend
activ
addit
select
digest
bp
ph
intact
lymph
node
cell
report
reaction
constitut
common
mechan
initi
myelin
destruct
inflammatori
lesion
due
remark
sensit
bp
proteolysi
secluenc
histolog
biocherm
chang
experiment
demyelin
well
known
wallerian
degener
cn
much
protract
pn
loss
myelin
compon
cholest
l
ester
appear
diptheria
toxin
viru
induc
demyelin
studi
experiment
chang
brain
hydrolas
activ
document
experiment
viral
enceph
mice
slow
viru
infect
anim
anim
model
eg
visna
demyelin
inflammatori
reaction
smith
lymph
node
neutral
proteinas
act
myelin
basic
protein
j
neurochem
multipl
sclerosi
ms
far
yet
known
occur
man
closest
approach
anim
model
diseas
experiment
allerg
encephalomyel
eae
autolog
homolog
heterolog
brain
spinal
cord
incorpor
immunolog
adjuv
use
induc
eae
encephalitogen
activ
due
organspecif
speciesspecif
antigen
constitu
thu
brain
spinal
cord
myelin
basic
protein
activ
peptid
fragment
togeth
freund
complet
adjuv
fca
kill
mycobacteria
paraffin
oil
caus
neurolog
symptom
intraderm
inject
follow
transfer
encephalitogen
antigen
plu
adjuv
lymph
node
short
latent
period
mycobacteria
stimul
direct
immun
reaction
specif
sensit
cell
produc
diseas
delay
hypersensit
reaction
effect
transfer
sensit
donor
anim
mean
lymph
node
cell
suspens
although
consider
variat
latent
period
sensit
differ
speci
neurolog
symptom
usual
appear
day
inject
clinic
sign
order
appear
includ
atax
gait
paresi
paralysi
hind
leg
faecal
impact
urinari
retent
monkey
cat
dog
vari
neurolog
symptom
develop
wax
wane
major
sign
occasion
clinic
remiss
follow
abrupt
relaps
rodent
dose
type
encephalitogen
antigen
natur
adjuv
rout
inject
age
anim
influenc
respons
hyperacut
eae
extrem
sever
uniformli
lethal
diseas
produc
activ
immun
neural
antigen
doubl
adjuv
system
highli
suscept
lewi
strain
rat
sever
case
anim
lose
weight
develop
ataxia
paralysi
hind
leg
acut
eae
also
follow
monophas
cours
chronic
relaps
form
develop
anim
show
mslike
pictur
remiss
exacerb
chronic
form
eae
induc
immatur
inbr
guinea
pig
singl
snesit
reduc
amount
antigen
adjuv
character
two
remiss
relaps
state
gradual
deterior
reduc
anim
moribund
state
acut
eae
primarili
inflammatori
condit
rare
associ
gross
lesion
central
nervou
system
cn
identifi
lesion
eae
cn
predominantli
spinal
cord
small
anim
extend
brain
larger
anim
particularli
primat
light
microscopi
show
sharpli
circumscrib
foci
vascular
perivascular
inflamm
within
brain
spinal
cord
affect
white
matter
grey
gross
lesion
uncommon
perivascular
accumul
fibrinogen
reflect
increas
permeabl
blood
brain
barrier
detect
prior
cellular
infiltr
exud
plasma
note
cn
extracellular
space
experi
appear
cerebr
vascular
permeabl
increas
establish
histolog
chang
eae
reactiv
chang
involv
cn
glial
cell
surround
focal
vascul
consist
prolifer
mieroglia
histiocyt
astrocyt
acut
eke
anim
gliosi
plaqu
lesion
compar
found
ms
seen
although
astrocyt
activ
result
deposit
glial
fibr
oedema
swell
myelin
earliest
observ
chang
sometim
cell
seen
phagocytos
myelin
howev
demyelin
occur
tissu
heavili
infiltr
haematogen
mononuclear
cell
axon
gener
spare
periven
infiltr
mononuclearcel
lymphocyt
small
monocyt
start
day
sensit
plasma
cell
appear
day
later
perivascular
cuff
choroid
plexu
mening
guinea
pig
rabbit
focal
mening
cellular
infiltr
commonest
histolog
featur
lo
dens
accumul
mononuclear
cell
subarachnold
space
anatom
connect
white
matter
rais
question
whether
inflammatori
respons
involv
antigen
surround
cerebrospin
fluid
csf
usual
lesion
consist
predominantli
mononuclear
cell
histiocyt
lymphocyt
plasma
cell
polymorphonuelear
pmn
cell
uncommon
earli
lesion
inflammatori
cell
cn
immunolog
commit
encephalitogen
ii
monkey
dog
pmn
cell
numer
lesion
may
resembl
microabcess
scatter
throughout
cn
includ
occasion
optic
nerv
prolifer
astrocyt
glial
reaction
resembl
gliosi
plaqu
lesion
ms
demyelin
occur
absenc
mononuclear
cell
anim
chronic
relaps
eae
old
recent
demyelin
plaqu
commonest
featur
spinal
cord
brain
cerebellum
chronic
eae
week
relaps
note
dissemin
natur
lesion
spinal
cord
l
chronic
plaqu
seen
dorsal
column
anterior
column
right
later
column
reproduc
kind
permiss
rain
cowork
hh
chronic
eae
week
post
inocul
relaps
recent
perivascular
cuff
rim
demelinatlng
axon
macrophag
myelin
debri
reproduc
kind
permiss
rain
cowork
plaqu
may
larg
enough
seen
nake
eye
resembl
close
patholog
ms
lesion
fig
one
strike
differ
ms
classic
acut
eae
greater
number
plasma
cell
seen
lesion
former
chronic
relaps
model
eae
similar
predomin
plasma
cell
seen
conjunct
rel
greater
demyelin
suggest
antibodi
involv
anim
model
ms
strongest
evid
eae
immunolog
diseas
transfer
sensit
lymphoid
cell
deriv
thymu
cell
interact
encephalitogen
antigen
resid
nelin
correl
found
diseas
onset
progress
delay
hypersensit
reaction
product
macrophag
inhibitori
faetor
mif
periton
exud
cell
harvest
guinea
pig
day
sensit
spinal
cord
plu
adjuv
specif
inhibit
extract
adult
rat
brain
neonat
rat
brain
lack
encephalitogen
antigen
extract
affect
sensit
cell
nevertheless
multipl
antigen
determin
myelin
basic
protein
bp
shown
studi
spitler
cowork
shown
mif
product
eae
activ
clearli
dissoci
studi
immunospecifi
purifi
antibp
igg
effect
antigen
valenc
bp
found
approxim
h
anoth
import
question
whether
oligodendrocyt
contain
antigen
bp
capabl
produc
eae
found
exogen
myelin
bp
remov
bovin
oligodendrocyt
cell
adjuv
produc
diseas
suggest
donot
contain
specif
encephalitogen
antigen
humor
immun
genral
accept
induct
eae
function
cellular
immun
system
independ
humor
antibodi
product
howev
monoantigen
system
bp
lebar
voisin
found
level
antibp
antibodi
igg
l
measur
passiv
cutan
anaphylaxi
pca
correl
protect
clinic
symptomslwhil
level
complement
fix
cf
antibodi
correl
sever
lesion
cf
igg
antibodi
induc
bp
whole
brain
homogen
becom
attach
cn
bornstein
appel
demonstr
rabbit
eae
sera
cf
antibodi
abl
demyelin
cultur
brain
cell
inhibit
primari
myelin
format
factor
howev
induc
whole
brain
encephalitogen
bp
myelin
claim
antimyelin
factor
anticerebrosid
antibodi
rabbit
lebar
cowork
recent
report
experi
show
demyelin
factor
autoantibodi
igg
class
direct
myelin
antigen
bp
cerebrosid
cellular
chane
although
eae
good
correl
morpholog
chang
cn
clinic
sign
mark
fluctuat
circul
lymphocyt
popul
correl
well
sever
clinic
sign
traugott
cowork
found
contrast
circul
b
cell
total
cell
valu
show
littl
chang
earli
activ
high
affin
roset
cell
level
show
signific
decreas
coincid
clinic
worsen
acut
eae
eae
anim
clinic
sign
develop
llth
day
post
inocul
percentag
circul
activ
cell
fell
time
prior
death
throughout
period
late
cell
show
minor
fluctuat
b
cell
number
slightli
elev
eae
suppress
strain
guinea
pig
inject
day
sensit
bovin
guinea
pig
myelin
bp
suppress
anim
day
post
inocul
transient
clinic
sign
appar
anim
recov
complet
three
twelv
mild
relaps
period
clinic
respons
day
percentag
earli
cell
decreas
significantli
control
clinic
recoveri
return
earli
cell
popul
slightli
elev
number
anim
later
relaps
mark
decreas
percentag
earli
cell
suggest
might
select
destruct
earli
cell
loss
activ
cellsmay
due
migrat
cn
known
invad
mononuclear
inflammatori
cell
traugott
cowork
next
measur
circul
activ
cell
assess
level
cn
use
ultrason
releas
infiltr
cell
mening
surfac
spinal
cord
lymphocyt
detect
mening
normal
anim
sick
anim
day
migrat
lymphoeyt
mening
tabl
proport
activ
cell
percentag
higher
found
blood
normal
guinea
pig
correl
percentag
earli
cell
mening
cell
suspens
sever
clinic
sign
therefor
conclud
decreas
earli
cell
circul
caus
migrat
target
organ
cn
myelin
fibr
rabbit
eye
provid
use
model
studi
immunolog
mediat
demyelin
wisniewski
cowork
shown
cellular
humor
activ
may
involv
supernat
factor
lymphokin
prepar
rabbit
lymphocyt
activ
nonspecif
mitogen
inject
vitreou
eye
normal
rabbit
sensit
wth
fca
infiltr
mononuclear
cell
damag
myelin
howev
rabbit
sensit
homolog
spinal
cord
demyelin
lesion
within
retin
fibr
induc
lymphocyt
product
inflat
high
level
monocyt
cn
differ
highli
signific
p
column
except
b
cell
differ
p
column
p
except
total
cell
guinea
pig
kill
day
inject
autolcg
spinal
cord
complet
freund
adjuv
traugott
cowork
primari
demyelin
could
also
induc
retin
fibr
normal
rabbit
eye
anticn
antibodi
combin
lymphokin
nonspecif
activ
lymphocyt
sera
normal
fcasensit
rabbit
unabl
induc
primari
demyelin
even
inject
lymphocyt
product
antibodydepend
demyelin
therefor
precipit
sensit
lymphocyt
activ
cn
antigen
result
releas
factor
attract
mononuclear
cell
increas
vascular
permeabl
examin
csf
earli
advanc
phase
eae
show
pleocytosi
usual
initi
pmn
respons
follow
predomin
lymphocyt
concentr
igg
increas
csf
rabbit
concentr
albumin
csf
plasma
respect
differ
two
group
increas
uptak
brain
anim
eae
evid
suggest
least
yglobulin
synthes
within
cn
tourtellott
parker
shown
posit
correl
concentr
igg
ms
plaqu
appar
normal
white
matter
concentr
csf
conclud
increas
csf
reflect
excess
igg
cn
recent
report
suggest
eae
sheep
passiv
transfer
protein
serum
csf
like
caus
protein
igg
increas
eae
develop
albumin
globulin
ratio
serum
csf
becam
nearli
ident
control
anim
ratio
csf
serum
respect
unlik
ms
antibodwa
direct
myelin
bp
appearedin
csf
ngml
onset
symptom
bound
antigenantibodi
complex
antibodi
bp
also
appear
csf
anim
without
clinic
histolog
eae
free
bound
myelin
bp
detect
eae
demyelin
take
place
presenc
inflammatori
cell
macrophag
seen
penetr
engulf
myelin
sheath
although
activ
demyelin
associ
cellular
exud
acut
case
ms
evid
activ
strip
myelin
sheath
phagocyt
cell
absent
eaeaffect
brain
infiltr
mononuclear
cell
surround
myelin
sheath
becom
hydrat
split
intraperiod
line
mononuclear
cell
invad
sheath
mesaxon
strip
outer
vesicular
lamella
final
myelin
fragment
phagocytos
transform
globoid
lipid
inclus
import
observ
made
yonezawa
cowork
demonstr
time
laps
cinematographi
endogen
phagocyt
respons
attack
myelin
sera
myelinotox
activ
anim
eae
experiment
allerg
neuriti
fan
ad
tissu
cutlur
indic
protein
first
site
attack
demyelin
process
came
histochem
find
proteolyt
activ
increas
periventricular
white
matter
guinea
pig
develop
lesion
support
hypothesi
base
observ
increas
incorpor
radioact
amino
acid
brain
protein
melin
nonmyelin
fraction
slice
guinea
pig
acut
eae
increas
protein
synthesi
could
attribut
activ
synthesi
inflammatori
cell
hand
studi
amino
acid
activ
trna
synthesi
rabbit
mark
increas
activ
amino
acid
earli
stage
eae
prior
cell
infiltr
like
candiat
initi
demyelin
process
bp
select
loss
protein
ms
plaqu
associ
rais
proteolyt
activ
must
protect
fromh
action
acid
proteinas
purifi
brain
tissu
well
document
inform
rais
proteolyt
enzym
activ
cn
eae
review
recent
smith
rodent
inflammatori
lesion
cn
accompani
extens
demyelin
activ
acid
proteinas
increas
neutral
proteinas
cathepsin
comparison
control
rat
lesion
microscop
diffus
consist
predominantli
lymphocyt
macrophag
cathespsin
carboxypeptidas
act
synergist
cathepsin
acid
proteinas
consid
marker
macrophag
specif
activ
enzym
lymph
node
time
brain
stem
hyperacut
microscop
lesion
monkey
inflammatori
lesion
contain
pmn
cell
well
macrophag
acid
proteinas
activ
increas
neutral
proteinas
enrich
pmn
cell
cathepsin
control
cn
valu
myelin
bp
highli
suscept
digest
neutral
proteinas
elastas
cathepsin
g
pmn
cell
none
enzym
chang
seen
day
inject
spinal
cord
onset
clinic
symptom
buletza
smith
found
increas
proteolyt
activ
throughout
ph
rang
spinal
cord
rat
acut
eae
optimum
ph
acid
hydrolysi
myelin
bp
coincid
haemoglobin
bp
myelin
protein
suscept
proteolysi
lipid
compon
myelin
also
subject
enzym
hydrolysi
much
membran
compris
lipid
number
investig
reveal
chang
lipolyt
enzym
eae
found
enhanc
activ
phospholipas
local
microsom
mitochondri
fraction
respect
rat
brain
acut
stage
eae
activ
phospholipas
increas
approxim
order
magnitud
wide
rang
diacylglycerophospholipid
phospholipas
higher
affin
diacyl
plasmalogen
analogu
activ
higher
eae
brain
activ
enzym
return
control
level
recoveri
stage
anoth
import
myelin
lipid
sulphatid
hydrolys
sulphatas
vasan
bachawat
report
arylsulphatas
b
rat
cn
show
maxim
activ
x
control
onset
eae
rapid
return
normal
acut
recoveri
stage
result
agre
earlier
find
increas
incorpor
sulphat
sulphatid
acut
stage
eae
suggest
higher
turnov
rate
increas
arylsulphatas
activ
acut
stage
eae
observ
maggio
cowork
less
signific
slower
rate
return
control
valu
although
signific
amount
proteolyt
enzym
present
normal
cn
tissu
brain
lysosom
stabl
thu
intrins
enzym
readili
avail
date
one
conclud
acid
andor
neutral
proteinas
initi
process
demyelin
bpdefici
myelin
isol
eae
ms
brain
howev
increas
proteolyt
activ
sever
fold
greater
lipid
degrad
enzym
increment
enzym
activ
eae
brain
consid
result
entri
phagocyt
cell
cn
wide
spectrum
lysosom
enzym
affect
includ
acid
phosphatas
time
extent
enzym
increas
correl
inflammatori
respons
summari
eae
delay
hypersensit
condit
activ
tlymphocyt
import
part
patholog
reaction
review
see
acut
condit
rodent
perivascldar
cuf
predomin
featur
unlik
ms
rel
restrict
demyelin
circul
antibodi
antigenmyelin
basic
protein
afford
protect
rather
initi
neurotox
effect
onset
paralysi
level
activ
cell
decreas
concomitantli
appear
cell
mening
affect
guinea
pig
rat
develop
eae
appear
myelin
fragment
blood
indirect
evid
suggest
myelin
bp
fragment
normal
rat
anim
eae
may
act
immunoregulatori
factor
influenc
develop
suscept
autoimmun
diseas
whether
endogen
myelin
bp
exert
put
immunosuppress
role
activ
suppressor
cell
clear
although
clinic
patholog
chang
acut
eae
close
seen
ms
inflammatori
reaction
import
diseas
howev
eae
anim
surviv
chronic
remit
condit
result
nearer
resembl
ms
condit
suppress
myelin
bp
py
paterson
transfer
allerg
encephalomyel
rat
mean
lymph
node
cell
j
exp
med
iii
paterson
py
experiment
autoimmun
allerg
encephalomyel
induct
pathogenesi
suppress
extent
distribut
demyelin
lesion
central
nervou
system
cn
vari
greatli
one
patient
multipl
sclerosi
ms
anoth
case
discret
focal
lesion
commonli
found
small
number
extens
confluent
demeylin
fig
frequent
found
close
ventric
es
beneath
pia
matter
sulci
cerebr
hemispher
optic
nerv
disabl
lesion
found
princip
corticospin
cerebellar
tract
sinc
area
predilict
close
contact
csf
suggest
demyelin
factor
may
associ
csf
addit
observ
lesion
gener
centr
around
small
vein
impli
activ
factor
case
blood
stream
may
penetr
brain
plaqu
rang
size
mm
sever
cm
suggest
ratio
microscop
gross
lesion
good
index
acut
process
demyelin
cn
final
result
format
dissemin
plaqu
dens
pack
astrogli
fibr
envelop
nake
axon
fig
freez
fractur
replica
ms
plaqu
nake
axon
ax
surround
process
astrocyt
cover
numer
assembl
arrow
x
reproduc
kind
permiss
duboisdalcq
hypercellular
character
activ
plaqu
fig
signific
perivascular
infiltr
investig
recent
adam
tabl
demyelin
plaqu
periven
inflammatori
cell
associ
activ
demyelin
durat
ill
correl
decreas
sever
activ
demyelin
perivascular
infiltr
ultrastructur
studi
cell
reveal
two
distinct
type
perlvascular
cuff
acut
type
seen
margin
plaqu
consist
lymphocyt
lymphoid
cell
lymphoid
cell
resembl
blast
type
lymphocyt
contain
consider
number
cell
organel
chronic
type
perivascular
cuff
consist
mainli
plasma
cell
characteris
increas
endoplasm
reticulum
macrophag
seen
vicin
plaqu
area
typic
chronic
plaqu
tissu
found
contain
plasma
cell
per
cubic
millimet
fresh
tissu
macrophag
partlcipateinth
phagocytosi
myelin
peel
strip
myelin
sheath
mononuclear
cell
observ
uncertainti
ident
cell
edg
plaqu
histochem
ground
ibrahim
adam
consid
oligodendrocyt
may
microgli
phagocyt
infiltr
monocyt
anoth
possibl
phagocytis
astrocyt
intact
myelin
fragment
rare
observ
within
cell
demyelin
cytoplasm
inclus
consist
membranebound
stack
curv
linear
profil
presum
product
myelin
degrad
observ
microglia
ms
plaqu
anoth
featur
earli
lesion
tissu
oedema
immedi
outsid
lymphocyt
cuff
appear
affect
myelin
lamella
cell
emphasis
inflammatori
natur
process
furthermor
immunoglobulincontain
cell
significantli
numer
plaqu
nonplaqu
recent
plaqu
compar
old
plaqu
lymphocyt
mening
frequent
accompani
activ
lesion
seri
case
ms
acut
chronic
jelling
found
inflammatori
lesion
mening
case
activ
demyelin
featur
mening
characteris
lymphocyt
monocyt
infiltr
often
enmesh
fibrin
network
number
lymphocyt
sequest
mening
area
within
sulci
often
exceed
number
within
brain
parenchyma
far
exce
number
free
cell
csf
tabl
inde
pleocytosi
csf
ms
patient
exacerb
may
maximum
number
free
ml
csf
x
adam
indic
ongo
lymphocyt
mening
activ
case
ms
ii
perivascular
cuff
lymphocyt
seen
outsid
plaqu
area
rel
intact
sometim
oedemat
myelin
stage
perivascular
cuff
contain
phagocyt
cell
predominantli
compos
small
lymphocyt
indic
inflammatori
respons
suggest
demyelin
initi
inflammatori
reaction
altern
explan
state
group
worker
place
less
emphasi
involv
inflammatori
cell
initi
progress
demyelin
lesion
jelling
case
activ
demyelin
absenc
inflammatori
cell
featur
brain
biopsi
specimen
studi
electron
microscop
suzuki
cowork
gonata
arstila
cowork
lh
common
myelin
abnorm
seen
focal
granular
degener
sheath
absenc
adventiti
cell
show
nonspecif
degen
chang
prolifer
fibrou
astrocyt
observ
hypercellular
zone
around
activ
plaqu
inclusionbear
cell
small
dark
nuclei
found
cell
distinguish
normal
oligodendrocyt
astrocyt
presenc
cytoplasm
process
membranebound
inclus
appear
within
smooth
endoplasm
reticulum
electron
cytochem
studi
arstila
cowork
detect
increas
enzym
activ
presenc
myelinlik
materi
astrocyt
lysosom
lh
studi
reactiv
cell
consid
unidentifi
macrophag
particular
interest
context
observ
duboisdalq
cowork
burnt
plaqu
immunoperoxidaselabel
antihuman
igg
stain
astrocyt
gliofibril
lysosom
fig
h
elev
titr
antibodi
measl
viru
present
sera
csf
signific
number
ms
patient
immunolog
data
rais
possibl
viral
aetiolog
diseas
ter
meulen
cowork
use
cell
fusion
techniqu
recov
parainfluenza
type
agent
brain
cell
grown
two
ms
biopsi
specimen
confirm
prinea
observ
paramyxoviruslik
intranuclear
filament
acut
lesion
one
ms
brain
cell
could
identifi
cytoplasm
fragment
contain
aggreg
tubul
outer
diamet
nm
core
diamet
nm
cross
striation
repeat
distanc
nm
similar
filament
present
mononuclear
cell
ms
brain
lesion
describ
tanaka
cowork
corona
viruslik
structur
also
reveal
electron
microscopi
doughnutshap
particl
diamet
cistern
rough
endoplasm
reticulum
cell
one
activ
lesion
electron
microscopi
cell
cultur
establish
brain
fail
reveal
similar
particl
addit
unusu
intranuclear
filament
ident
paramyxoviruslik
filament
found
circul
lymphocyt
ms
patient
patient
optic
neuriti
similar
structur
present
lymphocyt
neurolog
nd
l
ormal
control
sceptic
express
viral
natur
structur
rain
cowork
fail
demonstr
specif
paramyxoviru
antigen
filament
immunoelectron
microscopi
compar
studi
autopsi
tissu
number
unrel
diseas
establish
paramyxoviruslik
materi
specif
ms
may
relat
cellular
breakdown
immunoperoxidaselabel
antihuman
igg
chronic
ms
ultrastructur
local
human
igg
chronic
ms
plaqu
use
direct
immunoperoxidas
label
method
counter
stain
heard
salt
igg
present
astrocyt
membran
close
appos
basement
membran
around
blood
vessel
x
reproduc
kind
permiss
duboisdalcq
definit
proof
viral
aetiolog
ms
must
come
success
transmiss
infecti
agent
anim
host
howev
despit
interest
data
indic
possibl
infect
agent
remain
controversi
studi
inject
specimen
ms
patient
inbr
mice
observ
induc
chang
differenti
count
circul
leukocyt
decreas
percentag
absolut
number
polymorphonuclear
leukocyt
pmn
respons
factor
term
multipl
sclerosi
associ
agent
msaa
found
brain
spinal
fluid
serum
spleen
ms
patient
absent
control
sampl
appear
small
viru
pass
nm
nm
millipor
filter
could
transmit
second
passag
mice
similar
result
also
obtain
scrapi
pmn
depress
assay
subject
mani
variabl
result
confirm
test
code
specimen
difficult
time
assess
signific
independ
attempt
reproduc
result
unsuccess
associ
canin
distemp
viru
cdv
ms
suggest
result
find
increas
incid
ms
among
hous
dog
owner
survey
ms
patient
control
immunofluoresc
igg
antibodi
titr
distemp
viru
serum
significantli
elev
p
recent
cytopath
effect
observ
bone
marrow
ms
patient
recent
exacerb
inocul
cell
cultur
effect
observ
bone
marrow
control
inhibit
ms
patient
serum
serum
healthi
subject
etherl
isol
suggest
neutralis
experi
possibl
antigen
relationship
cdv
lesser
extent
measl
viru
suggest
agent
might
relat
way
paramyxovirus
possibl
involv
paramyxovirus
agent
ms
critic
discuss
hair
lesion
cn
show
site
predilect
area
contact
csf
close
blood
vessel
suggest
destruct
factor
kind
may
eman
blood
stream
activ
plaqu
show
glial
prolifer
mani
close
perivascular
cuff
inflammatori
cell
oedema
myelin
sheath
frequent
appear
earli
sign
intact
myelin
fragment
usual
observ
close
area
demyelin
report
microglia
contain
cytoplasm
inclus
consist
membranebound
stack
curv
linear
profil
ms
plaqu
least
chronic
case
perman
popul
plasma
cell
may
respons
continu
synthesi
antibodi
larg
number
cn
lymphocyt
sequest
recess
subarachnoid
space
surfac
cerebr
hemispher
antibodi
igg
deposit
plaqu
around
astrocyt
end
feet
appar
unaffect
area
may
destruct
oligodendrocyt
prolifer
astrocyt
although
paramyxoviruslik
inclus
seen
brain
bone
marrow
tissu
may
turn
artifact
histochem
examin
central
nervou
system
cn
multipl
sclerosi
ms
show
focal
area
demyelin
sudanophil
lipid
materi
accumul
marchiposit
stain
led
investig
examin
lipid
composit
affect
normal
tissu
success
achiev
leucodystrophi
discoveri
enzymat
marker
differ
cell
type
led
indic
appli
problem
identifi
cellular
reaction
ms
tissu
lipid
protein
analys
ms
plaqu
give
quantit
assess
myelin
loss
observ
histolog
increas
water
content
extens
loss
three
class
lipid
tabl
h
may
anticip
cerebrosid
characterist
myelin
galactolipid
deplet
plaqu
unexpectedli
accompani
loss
sulphatid
reduc
concentr
phosphatid
ethanelamin
major
myelin
phospholipid
balanc
increas
amount
lecithin
appear
cholesteryl
ester
one
hallmark
demyelin
trace
sterol
ester
present
normal
nervou
issu
earli
activ
plaqu
cholesterol
loss
account
ester
accumul
gangliosid
content
plaqu
increas
dri
weight
basi
decreas
wet
weight
basi
increas
extracellular
space
account
latter
result
increas
dri
weight
concentr
consist
assumpt
astrocyt
element
contain
gangliosid
myelin
plaqu
gangliosid
show
mani
chang
normal
white
matter
pattern
major
myelin
gangliosid
gmi
decreas
plaqu
complet
absenc
sialosyl
galactosylceramid
gangliosid
deriv
cerebrosid
unusu
gangliosid
uniqu
human
cn
concentr
white
matter
enrich
myelin
reduct
total
protein
content
plaqu
extens
lipid
loss
select
loss
basic
protein
appear
high
molecular
weight
peptid
demonstr
lesion
acut
chronic
ms
fig
proteolipid
protein
rel
resist
proteolyt
digest
higher
molecular
weight
protein
wolfgram
doublet
convert
lower
molecular
weight
form
wi
plaqu
tabl
myelin
protein
replac
glial
fibrillari
acid
protein
thu
account
small
chang
total
protein
brain
immunolobulin
g
twothird
ms
patient
elev
cerebrospin
fluid
csf
gamma
globulin
tourtellott
parker
report
investig
distribut
immunoglobulin
brain
patient
ms
found
elev
gamma
globulin
concentr
normal
appear
white
matter
grey
matter
plaqu
highest
level
found
close
edg
plaqu
lower
level
found
centr
plaqu
normal
appear
white
matter
distanc
plque
normal
appear
grey
matter
degre
perivascular
accumul
mononuclear
cell
correl
directli
degre
elev
data
support
hypothesi
prolifer
perivascular
cell
suffici
probabl
necessari
produc
elev
gamma
globulin
brain
tissu
ms
possibl
cell
advanc
margin
plaqu
might
also
produc
gamma
globulin
paper
suggest
elev
gamma
globulin
normal
white
matter
could
due
diffus
immunoglobulin
synthesis
activ
plaqu
increas
csf
globulin
likewis
reflect
excess
globulin
brain
elev
globulin
could
use
support
two
theori
aetiolog
ms
name
due
autoimmun
process
slow
viru
infect
report
sever
laboratori
abnorm
lipid
composit
white
matter
myelin
ms
point
primari
lipid
defect
myelin
significantli
lower
level
found
serin
phosphoglycerid
sulphatid
white
matter
myelin
clausen
hansen
woelk
borri
io
all
cowork
ii
result
support
earlier
find
cume
goodwin
gerstl
cowork
found
less
cerebrosid
concomit
increas
sulphatid
ms
myelin
howev
sampl
ms
brain
gerstl
cowork
found
lower
valu
serin
phosphoglycerid
comment
result
fatti
acid
pattern
ms
brain
strikingli
similar
normal
brain
ii
cerebrosid
sulphatid
h
significantli
increas
h
decreas
phospholipid
ms
brain
significantli
differ
fatti
acid
pattern
normal
brain
sphingomyelin
amount
longchain
unsatur
fatti
acid
reduc
particularli
hand
abnorm
lipid
composit
includ
gangliosid
found
myelin
isol
white
matter
patient
ms
chang
found
statist
signific
reduct
myelin
yield
report
chang
protein
normalappear
white
matter
ms
brain
myelin
fraction
isol
suzuki
cowork
contain
normal
amount
basic
proteolipid
protein
find
confirm
earlier
data
addit
wolfgram
found
normal
amino
acid
composit
ms
myelin
suggest
normal
protein
pattern
even
extens
diffus
form
demyelin
reflect
low
recoveri
myelin
isol
fraction
signific
composit
abnorm
chemic
composit
myelin
sheath
ms
white
matter
differ
slightli
control
white
matter
littl
evid
primari
composit
defect
deplet
acid
phospholipid
may
relat
earli
loss
basic
protein
damag
tissu
acid
lipid
interact
white
matter
case
progress
ms
short
durat
found
cholesteryl
ester
loss
cerebrosid
sulphatid
phospholipid
area
appear
normal
nake
eye
myelin
fraction
isol
normalappear
white
matter
case
acut
ms
unchang
composit
yield
myelin
reduc
result
chang
densiti
abnorm
myelin
may
lost
prepar
stage
differenti
centrifug
fatti
acid
composit
appar
normal
area
ms
white
matter
baker
cowork
extract
lecithin
white
matter
ms
case
recogniz
plaqu
tissu
visibl
eye
analysi
fatti
acid
composit
show
proport
satur
chain
increas
unsatur
chain
decreas
worker
found
differ
rang
satur
unsatur
fatti
acid
increas
found
palmit
decreas
palmitol
oleic
araehidon
vari
abnorm
result
found
worker
although
ail
cowork
ii
found
fatti
acid
pattern
ms
brain
strikingli
similar
normal
brain
minor
chang
found
white
matter
ester
fatti
acid
found
small
signific
alter
serum
lipid
fatti
acid
particular
found
reduct
linol
concentr
report
differ
linol
concentr
fast
blood
lipid
neurolog
case
compar
ms
suffer
howev
confirm
differ
patient
healthi
control
suggest
thompson
chang
indic
widespread
abnorm
handl
certain
fatti
acid
bodi
patient
ms
result
hypothesi
longterm
trial
polyunsatur
fatti
acid
pufa
supplement
patient
undertaken
moder
improv
length
relaps
patient
progress
diseas
known
prostaglandin
henc
reduc
synthesi
prostaglandin
may
featur
diseas
possibl
pufa
act
immunosuppress
clinic
effect
relat
properti
clausen
mller
found
increas
suscept
experiment
allerg
encephalomyel
eae
sever
cours
diseas
anim
bred
rais
pufa
diet
hand
dietari
supplement
pufa
exert
protect
effect
postul
releas
lysosom
enzym
activ
respons
initi
attack
myelin
sheath
measur
hydrolas
activ
give
indic
possibl
mechan
demyelin
pattern
rais
enzym
activ
may
use
attempt
identifi
cell
type
involv
chronic
plaqu
establish
chronic
lesion
minim
cell
cuf
largest
increas
activ
acid
phosphatas
follow
acid
proteinas
minim
activ
contrast
activ
myelin
marker
enzym
nucleotid
phosphohydrolas
dramat
decreas
reduct
acid
lipas
esteras
activ
suggest
enzym
local
myelin
oligodendrogli
cell
activ
plaqu
earli
activ
demyelin
plaqu
mark
perivascular
cuf
lymphocyt
prolifer
neurolog
cell
andor
macrophag
lysosom
hydrolas
activ
concentr
rim
plaqu
evid
increas
metabol
activ
centr
plaqu
sometim
hydrolas
level
unaffect
white
matter
addit
increas
acid
proteinas
phosphatas
activ
rais
level
glucuronidas
arylsulphatas
plasmalogenas
cathepsin
found
activ
plaqu
neutral
proteinas
activ
also
report
increas
plaqu
border
enzym
typic
found
pmn
leucocyt
present
myelin
degre
activ
signific
acid
proteinas
recent
studi
laboratori
acid
proteinas
activ
significantli
rais
activ
lesion
widespread
diffus
demyelin
accompani
accumul
macrophag
astrocyt
well
circumscrib
plaqu
associ
greater
degre
lymphocyt
cuf
vessel
increas
acid
proteinas
mark
macrophag
much
higher
acid
ratio
l
circul
lymphocyt
thu
high
acid
proteinas
level
found
fulmin
lesion
may
reflect
astrocytosi
macrophag
accumul
rel
greater
increas
bglucuronidas
activ
discret
plaqu
may
result
perivascular
infiltr
lymphocyt
chronic
burnt
plaqu
sourc
enzym
activ
must
attribut
fibrou
astrocyt
massiv
inflammatori
lesion
monkey
eae
hirsch
cowork
found
bglucuronidas
enzym
whose
activ
increas
tabl
einstein
cowork
e
result
chronic
acut
ms
respect
b
cuzner
davison
c
ansel
spanner
e
plaqu
chronic
ms
brain
f
plaqu
acut
ms
brain
plasmalogenas
like
phospholipas
hydrolys
intact
phospholipid
produc
lysophospholipid
myelinolyt
enzym
almost
exclus
locat
white
matter
studi
singl
ms
brain
plasmalogenas
activ
sever
plaqu
doubl
normalappear
white
matter
sourc
increas
plasmalogenas
activ
could
equal
well
infiltr
cell
activ
glial
cell
carboxypeptidas
cathepsin
act
synergist
cathepsin
enrich
macrophag
specif
activ
time
greater
brain
comparison
cathepsin
activ
cerebr
matter
unit
control
subject
mean
activ
plaqu
chronic
acut
case
ms
elev
respect
thu
find
increas
cathepsin
activ
ms
plaqu
consist
view
macrophag
least
one
sourc
increas
hydrolas
activ
normalappear
lite
matter
signific
elev
hydrolyt
enzym
activ
grossli
normal
white
matter
chronic
ms
brain
possibl
except
acid
proteinas
arstila
cowork
einstein
cowork
hirsch
cowork
found
acid
proteinas
activ
increas
larg
proport
ms
white
matter
sampl
comparison
control
studi
appar
normal
white
matter
two
acut
case
ms
bglucuronidas
level
significantli
increas
although
level
acid
proteinas
unchang
format
recogniz
denyelin
lesion
may
preced
enhanc
metabol
activ
aris
either
glial
cell
perivascular
lymphocyt
phospholipas
also
lysosom
local
observ
increas
approxim
macroscop
normal
white
matter
ms
brain
accompani
decreas
ethanolamin
plasmalogen
concentr
total
ethanolamin
phosphoglycerid
alter
thu
special
role
acid
proteinas
myelin
destruct
appear
unlik
increas
lysosom
hydrolas
may
result
rather
caus
myelin
breakdown
summari
seem
chang
found
white
matter
appar
normal
area
due
minut
area
damag
visibl
nake
eye
isol
myelin
cn
ms
patient
composit
similar
control
sampl
support
therefor
idea
composit
defect
myelin
onset
diseas
process
chronic
area
demyelin
show
loss
myelin
compon
affect
white
matter
accumul
cholesteryl
ester
glial
fibrillar
protein
acut
damag
lysosom
hydrolas
activ
increas
select
loss
myelin
basic
protein
appear
oi
lower
molecular
weight
peptid
attack
may
initi
action
neutral
possibl
acid
proteinas
phospholipas
plasma
ogenas
secret
activ
cell
establish
oligodendrogli
cell
first
affect
whether
myelin
basic
protein
expos
proteolysi
occur
hirsch
park
acid
proteinas
acid
hydrolas
experiment
allerg
encephalomyel
pinpoint
sourc
j
neurochem
h
woelk
k
peilerlchikawa
activ
phospholipas
compar
multipl
sclerosi
j
neurol
rel
test
prove
valu
routin
investig
patient
multipl
sclerosi
ms
use
test
measur
chang
immunoglobulin
g
igg
concentr
csf
associ
signific
alter
gold
colloid
precipit
curv
addit
inform
obtain
neurophysiolog
immunolog
procedur
neurophysiolog
techniqu
visualevok
potenti
vep
help
quantifi
degre
central
nervou
system
cn
damag
particular
subject
techniqu
vep
record
provid
estim
chang
size
affer
volley
reach
cortex
special
valu
acut
optic
neuriti
normal
impuls
conduct
may
complet
block
continu
transmiss
may
delay
may
inabl
transmit
faster
train
impuls
conduct
block
abil
fibr
transmit
fast
impuls
mostli
affect
temperatur
chang
occipit
respons
monocular
stimul
revers
black
white
checkerboard
success
use
longitudin
evalu
patient
remark
recoveri
amplitud
peak
latenc
observ
result
rais
import
possibl
remyelin
damag
optic
nerv
fibr
may
occur
patient
altern
vep
auditori
system
may
examin
use
standard
click
stimulu
auditoryevok
potenti
aep
complex
depend
structur
brain
stem
well
forebrain
high
proport
patient
clinic
evid
brainstem
demyelin
abnorm
auditoryevok
respons
without
appar
disturb
also
abnorm
spite
rariti
clinic
appar
deaf
believ
ultim
seri
evokedpotenti
data
singl
patient
enabl
hidden
plaqu
detect
patient
clinic
probabl
possibl
ms
thu
make
diagnosi
definit
recoveri
seen
patient
may
due
revers
effect
serum
factor
sera
ms
patient
also
anim
experiment
allerg
encephalomyel
eae
abil
revers
block
extracellularli
record
evok
electr
respons
cn
tissu
cultur
effect
distinct
demyelin
factor
seem
complementdepend
could
explan
transient
neurolog
chang
seen
ms
howev
block
factor
also
found
sera
normal
subject
comprehens
review
sell
h
conclud
evid
number
laboratori
exist
serum
factor
human
anim
speci
depress
electr
activ
vitro
prepar
disagr
exist
specif
factor
demyelin
diseas
sera
normal
rat
rabbit
hlmn
well
demyelin
diseas
shown
block
postsynapt
respons
mammalian
spinal
cord
hippoeampu
cerebr
neocortex
cultur
recent
studi
schauf
cowork
studi
neuroelectr
block
activ
sera
ms
patient
control
includ
patient
stroke
found
significantli
increas
block
activ
patient
within
week
acut
exacerb
tabl
activ
complementdepend
found
serum
igg
fraction
respons
antibodi
direct
measl
viru
nevertheless
role
serum
neuroelectri
block
factor
specif
nonspecif
pathogenesi
human
experiment
demyelin
diseas
remain
undefin
alter
seen
blood
ms
patient
report
blood
platelet
patient
ms
abnorm
sticki
adhes
invers
relat
serum
eholesteryl
linol
level
chang
red
blood
cell
ms
patient
relat
diseas
activ
also
found
increas
mean
erythrocyt
diamet
fragil
find
relat
possibl
defect
membran
lipid
composit
thu
report
defici
serum
polyunsatur
fatti
acid
pufa
sever
affect
patient
tabl
howev
chang
also
found
patient
neurolog
diseas
may
therefor
associ
disabl
discuss
see
chapter
immunolog
test
number
test
measur
cellular
immun
respons
ms
describ
none
yet
adopt
routin
diagnost
investig
exampl
respons
leucocyt
encephalitogen
myelin
basic
protein
bp
protein
use
basi
vitro
test
ms
respons
seem
vari
cours
diseas
kllen
cowork
use
techniqu
leucocyt
migrat
agaros
ms
patient
detect
chang
reactiv
bp
connect
relaps
six
ten
patient
show
signific
reactiv
within
day
relaps
respons
decreas
disappear
two
week
relaps
sometim
reappear
found
test
perform
month
later
propos
reactiv
epiphenomenon
due
cn
tissu
destruct
similar
result
obtain
patient
cerebr
infarct
levi
cowork
describ
blood
test
base
adher
peripher
blood
lymphocyt
measl
viruslhfect
tissu
cultur
purifi
popul
lymphocyt
patient
ms
form
rosett
vitro
mix
measl
virusinfect
epitheli
cell
similarli
prepar
lymphocyt
control
popul
show
much
less
roset
activ
overlap
patient
control
valu
suggest
assay
may
diagnost
import
posit
test
patient
ms
affect
sever
durat
activ
diseas
difficult
procedur
wide
rang
control
need
done
test
accept
routin
procedur
conflict
result
specif
cellmedi
immun
measl
viru
see
chapter
nonspecif
cellmedi
immun
reaction
vitro
one
recent
studi
nordal
ii
studi
two
patient
group
one
recent
later
week
onset
anoth
long
stand
diseas
found
signific
differ
lymphocyt
transform
reaction
number
mitogen
exclud
bp
measl
jin
rosett
format
cytotox
macrophag
electrophoret
mobil
test
mem
introduc
field
caspari
detect
malign
test
base
observ
peripher
blood
lymphocyt
patient
malign
diseas
sensit
bp
purifi
protein
deriv
ppd
incub
sensitez
lymphocyt
either
antigen
result
releas
macrophageslow
factor
lymphocyt
whose
presenc
may
detect
effect
electrophoret
mobil
guinea
pig
macrophag
peripher
blood
lymphocyt
patient
ms
appear
much
suscept
inhibitori
activ
linol
acid
test
sensit
ppd
mem
test
normal
subject
differ
claim
specif
ms
could
use
vitro
diagnost
test
diseas
howev
conflict
report
valu
mem
test
diagnosi
cancer
diagnosi
ms
diagnost
test
ms
human
red
blood
cell
develop
test
claim
erythrocyt
patient
ms
show
signific
reduct
electrophoret
mobil
presenc
linol
acid
wherea
erythrocyt
patient
normal
subject
show
increas
mobil
effect
linol
acid
electrophoret
mobil
red
blood
cell
ms
patient
normal
subject
studi
stoof
cowork
extens
statist
evalu
data
clearli
demonstr
differ
behaviour
red
blood
cell
patient
normal
subject
presenc
linol
acid
even
tendenc
mobil
erythrocyte
decreas
patient
increas
normal
subject
addit
linol
acid
observ
similar
observ
report
forrest
smith
found
chang
erythrocyt
mobil
linol
acid
although
total
mean
protein
content
ml
csf
time
less
serum
level
igg
disproportion
lower
total
protein
serum
csf
ms
concentr
total
protein
rare
exce
ml
ms
patient
increas
concentr
igg
csf
total
protein
increas
persist
throughout
ill
sinc
serum
protein
abl
leak
spinal
fluid
result
damag
capillari
eg
plaqu
near
ventricl
corrrect
must
made
possibl
passiv
transfer
relat
igg
valu
anoth
high
molecular
weight
serum
protein
eg
macroglobulin
albumin
thu
tourtellott
correct
contribut
serum
antibodi
utilis
rel
csf
serum
igg
albumin
concentr
appli
valu
correct
formula
olsson
pettersson
advoc
use
igg
index
csfserum
igg
ratio
divid
csf
serum
albumin
ratio
increas
index
found
ms
patient
neurolog
diseas
allow
ms
clearli
still
diseas
amount
igg
csf
much
higher
explain
simpl
transfer
antibodi
serum
also
conclud
frick
scheidseydel
found
basi
exchang
intraven
igg
serum
csf
immunoglobulin
synthes
brain
ms
patient
addit
cohen
bannist
demonstr
csf
lymphocyt
ms
patient
synthes
igg
iga
igm
newli
form
igg
rel
amount
kappa
lambda
determin
igg
present
csf
find
confirm
sandbergwollheim
cowork
found
igg
iga
synthes
csf
lymphocyt
ms
patient
particularli
relaps
synthes
igg
oligoclon
distribut
show
electrophoret
pattern
igg
origin
csf
blood
lymphocyt
patient
synthes
igg
vitro
show
complet
differ
electrophoret
pattern
furthermor
amount
igg
synthes
blood
lymphocyt
less
amount
synthes
csf
cell
result
demonstr
least
part
oligoclon
igg
csf
ms
patient
synthes
intrathec
suggest
csf
cell
antigen
stimul
within
cn
vivo
ml
csf
form
absorb
daili
normal
adult
appear
averag
ms
patient
cn
produc
excess
mg
igg
per
day
rang
mg
synthesi
depress
steroid
therapi
parallel
clinic
improv
oligoclon
band
normal
subject
igg
region
electrophoret
separ
csf
diffus
homogen
appear
ms
diseas
nervou
system
known
infecti
aetiolog
eg
mump
herp
enceph
multifoc
leukoencephalopathi
sarcoid
restrict
heterogen
igg
seen
oligoclon
band
antibodi
rel
diffus
probabl
repres
immunodomin
antigen
stimul
sever
clone
lymphocyt
produc
antibodi
ms
patient
oligoclon
band
detect
addit
patient
alter
ratio
kappa
lambda
light
chain
suggest
abnorm
natur
igg
molecul
kappa
type
protein
pronounc
ms
condit
chronic
antigen
stimuli
eg
herp
measl
free
light
chain
identifi
csf
patient
subacut
sclerosi
panenceph
sspe
found
ms
patient
free
light
chain
may
link
zetterval
deriv
proteolysi
oligoclon
immunoglobulin
synthes
within
cn
may
defect
assembl
complet
antibodi
molecul
chang
seen
yglobulin
csf
pattern
longitudin
studi
csf
ms
patient
vandvik
recent
report
suggest
oligoclon
band
pattern
alter
cours
ill
natur
antibodi
specif
igg
isol
nervou
tissu
csf
ms
sspe
patient
mainli
igg
subclass
oligoclon
measlesspecif
antibodi
isol
sera
csf
brain
antibodi
case
sspe
lesser
extent
ms
patient
latter
case
antibodi
elut
mg
igg
serum
brain
plaqu
tissu
contain
sever
band
igg
igg
subclass
detect
serum
wherea
igg
found
plaqu
use
haemagglutinationinhibit
test
immunoelectrophoresi
unpurifi
cellassoci
viru
antigen
crossreact
primarili
iggl
subclass
howev
measl
viru
antigen
identifi
ms
plaqu
choroid
plexu
lymphocyt
oligoclon
band
csf
absorb
measl
viru
antigen
concentr
sampl
csf
analyz
igg
igg
subclass
protein
found
igg
quantit
csf
individu
rel
high
serum
igg
content
use
specif
antisera
subclass
shown
igg
subclass
present
csf
ms
patient
normal
individu
although
total
igg
content
csf
ms
patient
rais
compar
valu
obtain
csf
normal
usual
reflect
increas
level
igg
igg
increas
igg
level
predominantli
reflect
increas
igg
subclass
level
appear
like
observ
increas
igg
level
indic
select
local
stimul
antibodi
synthesi
rather
select
transport
across
blood
brain
barrier
csf
antibodi
direct
varieti
paramyxoviru
detect
antibodi
account
small
proport
total
frequent
seen
neurolog
diseas
csf
complementfix
antibodi
react
crude
ms
brain
detect
laurel
link
ryberg
proport
antibodi
establish
finer
analysi
antibodi
spectrum
csf
oligoclon
band
achiev
electrofocus
fig
cell
patient
remiss
relaps
total
leucocyt
count
csf
normal
ie
less
patient
count
exceed
polymorphonuelear
leucocyt
pmnl
csf
rare
seen
ms
less
pmnl
howev
tourtellott
report
case
ms
pmnl
whitak
find
pmnl
acut
case
ms
tabl
ms
case
number
plasma
cell
may
increas
report
increas
lymphocyt
csf
acut
relaps
macrophag
may
present
see
chapter
similarli
allen
cowork
found
relaps
percentag
cell
increas
diminish
second
week
attack
reach
remiss
find
contrast
variat
found
peripher
blood
b
cell
popul
ms
patient
report
increas
b
thymic
independ
lymphocyt
subject
ms
decreas
thymicdepend
lymphocyt
blood
patient
acut
ms
apart
neurophysiolog
examin
studi
csf
antibodi
investig
routin
valu
ms
test
lymphocyt
function
macrophag
electrophoret
mobil
still
controversi
although
investig
suggest
abnorm
cellular
immun
respons
serum
complementdepend
neuroelectr
block
antibodi
found
relaps
may
account
revers
clinic
sign
occur
exacerb
examin
csf
protein
especi
electrophoret
separ
oligoclon
band
consider
diagnost
valu
seem
clear
much
antibodi
synthes
within
cn
import
report
oligoclon
band
pattern
alter
cours
ill
occasion
polymorph
activ
cell
appear
csf
exacerb
small
chang
total
serum
antibodi
concentr
patient
ms
report
possibl
ascrib
elev
level
directli
ms
virusspecif
antibodi
detect
serum
csf
exampl
increas
titr
report
antibodi
differ
myxovirus
eg
measl
herp
parainfluenza
rubella
account
small
proport
igg
csf
serum
recent
preliminari
find
antibodi
direct
oligodendroglia
found
sera
ms
patient
antibodi
present
case
subaeut
scleros
panenceph
sspe
patient
neurolog
diseas
normal
control
abramski
cowork
use
indirect
immunofluoresc
techniqu
detect
antibodi
bind
isol
bovin
oligodendrocyt
human
brain
section
antibodi
could
remov
preincub
isol
oligodendrocyt
whole
white
matter
myelin
nonnerv
tissu
similar
immunofluoresc
stain
seen
rabbit
antioligodendrocyt
serum
serum
could
block
reaction
ms
serum
antibodi
antibodi
direct
encephalitogen
basic
protein
found
serum
ms
patient
may
appear
csf
time
exacerb
myelinolyt
gliotox
factor
serum
bornstein
appel
observ
serum
rabbit
experiment
allerg
encephalomyel
eae
caus
demyelin
cerebellar
explant
tissu
cultur
later
found
serum
ms
patient
smaller
number
control
subject
contain
similar
factor
demyelin
factor
found
patient
activ
ms
diseas
statu
less
sure
remiss
present
control
case
motor
neuron
diseas
factor
report
present
igm
igg
fraction
sera
patient
activ
ms
serum
antimyelin
factor
induc
encephalitogen
agent
myelin
basic
protein
antibas
protein
antibodi
antimyelin
effect
vitro
myelin
compon
induc
factor
yet
identifi
although
galactocerebrosid
shown
rais
rabbit
wolfgram
duquett
made
import
observ
myelinotox
action
ms
sera
could
absorb
nonmyelin
white
matter
membran
fraction
includ
glial
membran
well
intracellular
membran
demyelin
action
remov
incub
purifi
myelin
although
contrast
myelin
neutral
demyelin
activ
eae
sera
similar
fraction
peripher
nerv
effect
neutral
myelinolyt
activ
wolfgram
duquett
conclud
antibodi
involv
demyelin
ms
patient
probabl
antioligodendrocyt
rather
antimyelin
despit
similar
phenomena
human
experiment
condit
result
would
suggest
demyelin
factor
ms
induc
differ
antigen
eae
may
differ
mean
regard
pathogenesi
also
seem
probabl
ii
inhibitori
action
serum
acut
ms
patient
incorpor
myelin
protein
rat
brain
slice
attribut
action
glial
myelin
synthesi
vitro
studi
sever
group
shown
ms
sera
toxic
glial
cell
cultur
doubt
use
gliotox
sole
index
presum
diseaserel
effect
rain
cowork
studi
primari
demyelin
organotyp
cultur
mous
spinal
cord
produc
myelinotox
ms
sera
show
myelin
degener
transform
regular
nm
period
smudg
amorph
structur
eventu
degener
myelin
phagocytos
invest
astrogliai
cell
cytoplasm
axon
surround
astrocyt
whorl
remain
growth
oedemat
astrocyt
oligodendrocyt
appear
undergo
degener
affect
oligodendrocyt
phagocytos
follow
ensheath
astrocyt
process
neuron
astrocyt
degener
immun
complex
reaction
antibodi
antigen
result
solubl
immun
complex
format
thought
result
continu
antigen
stimul
rais
igg
concentr
csf
major
ms
patient
consist
featur
diseas
addit
good
evid
serum
immun
complex
format
ms
raji
cell
assay
circul
immun
complex
detect
sera
ms
case
sera
normal
control
circul
immun
complex
also
found
rais
ms
patient
jacqu
cowork
ms
patient
longitudin
trial
found
larger
proport
patient
ms
optic
neuriti
slightli
elev
level
serum
immun
complex
compar
normal
neurolog
control
differ
reach
statist
signific
correl
found
clinic
statu
complex
level
longitudin
studi
five
patient
studi
method
nydegg
label
b
cowork
use
measur
complex
q
ufract
first
compon
complement
initi
complement
activ
bind
complex
immunoglobulin
raji
cell
receptor
specif
complex
bound
clq
may
explain
discrep
result
highli
signific
result
tachovski
cowork
data
suggest
deposit
complex
within
brain
ms
patient
increas
concentr
igg
demonstr
plaqu
materi
ms
brain
immunofluoresc
immunoperoxidas
studi
carri
ms
plaqu
reveal
presenc
myelinbound
igg
well
lymphoid
astrocyt
cell
iggrich
cytoplasm
granular
deposit
clq
locat
igg
lend
support
view
igg
found
ms
plaqu
part
immun
complex
aggreg
form
deposit
immun
complex
inflammatori
reaction
may
result
deposit
antigenantibodi
immun
complex
review
see
movat
associ
inflammatori
reaction
rang
increas
vascular
permeabl
sever
haemorrhag
necrot
lesion
presenc
excess
circul
antigen
solubl
immun
complex
form
eg
serum
sick
remov
reticuloendotheli
system
primarili
arter
glomerulonephr
arthriti
develop
small
size
complex
thu
form
favour
deposit
tissu
antibodi
produc
mainli
igg
igm
ige
also
found
interact
latter
fix
mast
cell
basophil
antigen
lead
releas
vasoact
amin
complex
appear
trap
special
filtrat
structur
eg
renal
glomerulu
choroid
plexu
permeabl
serum
protein
deposit
circul
complex
requir
increas
vascular
permeabl
probabl
mediat
vasoaet
amin
larg
deriv
platelet
presenc
high
circul
antibodi
introduct
small
amount
antigen
induc
arthu
reaction
character
hyperaemia
exud
swell
haemorrhag
necrosi
addit
immun
complex
complement
polymorphonuclear
leucocyt
pmnl
necessari
inflammatori
reaction
pmnl
phagocytos
deposit
immun
complex
becom
degranul
releas
lysosom
enzym
surround
tissu
pmnl
antisenantibodi
induc
tissu
inur
pmnl
macrophag
exert
deleteri
effect
experiment
inflammatori
diseas
eg
acut
glomerulonephr
arthriti
vascul
thu
arthu
vascul
inhibit
specif
remov
neutrophil
rabbit
serum
sick
usual
necrot
arter
appear
neutrophil
remov
antigenantibodi
complex
phagocytos
pmnl
number
phlogist
substanc
secret
includ
proteas
acid
proteinas
degrad
basement
membran
batteri
neutral
proteinas
secret
includ
elastas
collagenas
cathepsin
g
pmnl
constitu
thought
involv
activ
thrombin
complement
possibl
c
cation
frotein
present
pmnl
bactericid
properti
also
vasoact
increas
vascular
permeabl
immun
complex
also
induc
select
releas
acid
hydrolas
macrophag
chronic
inflamm
plasminogen
activ
lysozym
activ
secret
inflammatorz
respons
blood
csf
report
increas
pmnl
neutral
proteinas
np
blood
patient
ms
relaps
point
alter
respons
phagocyt
cell
immun
system
time
well
small
chang
total
activ
distribut
enzym
shift
granul
cytoplasm
fraction
np
significantli
elev
acid
proteinas
ap
lower
patient
clinic
definit
ms
suffer
relaps
within
preced
month
correlaticn
enzym
activ
lesion
site
degre
diabil
fig
despit
difficulti
establish
exact
time
relationship
longitudin
anaylsi
two
case
rise
enzym
activ
appear
preced
clinic
relaps
np
activ
predominantli
locat
pmnl
fluctuat
neutral
acid
proteinas
activ
would
appear
directli
relat
diseas
activ
cn
relat
extracerebr
immun
reaction
could
alter
function
properti
pmnl
alter
np
activ
suggest
inflammatori
reaction
accompani
relaps
ms
pmnl
appear
rare
csf
exacerb
ef
ms
use
highli
sensit
method
radioact
basic
protein
substrat
possibl
separ
cell
probabl
macrophag
polymerph
contain
np
littl
np
activ
found
lymphocyt
csf
comparison
np
activ
pmnl
infecti
diseas
cn
proport
cell
count
np
activ
csf
cellular
fraction
significantli
increas
ms
patient
relaps
compar
remiss
although
pmnl
macrophag
identifi
csf
even
low
number
would
account
observ
np
activ
presenc
increas
lysozym
level
known
secret
pmnl
andmacrophag
appear
myelin
fragment
csf
ms
patient
exacerb
also
indic
inflammatori
demyelin
cohen
cowork
whitak
report
increas
basic
protein
fragment
csf
correl
clinic
stage
diseas
also
effect
inhibitor
peainduc
lymphocyt
activ
impair
lymphokin
product
secret
sensit
lymphocyt
feedback
control
system
defect
sensit
small
lymphocyt
prostaglandin
may
one
way
chronic
persist
inhibit
prostaglandin
synthesi
nonsteroid
antiinflammatori
drug
indomethacin
may
necessarili
act
effect
control
point
less
activ
pgsynthetas
inhibitor
acetylsalicyl
acid
rel
success
drug
treatment
chronic
diseas
rheumatoid
arthriti
thu
pg
analogu
may
potenti
use
control
chronic
inflmmatori
condit
ms
find
lymphocyt
perivascular
cuff
close
lesion
ms
alter
report
properti
circul
cell
support
view
delay
hypersensit
reaction
virus
antigen
could
oper
ms
offner
cowork
confirm
observ
zabriski
cowork
cellular
anergi
measl
antigen
radioact
thymidin
myoinositol
incorpor
ms
lymphocyt
decreas
stimul
pha
measl
antigen
compon
impair
lymphocyt
function
suggest
possibl
failur
part
lymphocyt
identifi
antigen
viru
defect
type
may
relat
inherit
factor
indic
determin
see
chapter
hand
posit
correl
found
cellular
hypersensit
myelin
basic
protein
bp
relat
clinic
attack
ms
result
lymphoblast
transform
macrophag
migrat
inhibitori
factor
mif
assay
relat
tempor
cours
ms
mif
assay
normal
control
subject
gave
mean
valu
wherea
patient
studi
within
week
onset
ill
gave
result
convalesc
chronic
group
gave
mean
respect
differ
portion
bp
molecul
may
stimul
sensit
lymphocyt
produc
specif
lymphokin
exampl
posit
lymphoblast
transform
result
contrast
neg
result
mif
ms
lymphocyt
stimul
amino
acid
ctermin
fragment
bp
cellular
hypersensit
brain
fraction
myelin
protein
report
offner
cowork
definit
chang
cell
activ
found
csf
small
number
lymphocyt
appear
relaps
tabl
csf
allen
cowork
found
relaps
percentag
cell
first
week
increas
diminish
second
week
attack
reach
remiss
direct
variat
cell
accompani
increas
unreact
cell
implic
cellular
immun
mechan
pathogenesi
ms
worker
suggest
increas
proport
unreact
cell
csf
may
suppress
toler
myelinotox
cell
inactiv
coat
antigen
antigenantibodi
complex
prospect
studi
patient
sandbergwollheim
turesson
found
increas
number
iggposit
cell
csf
compar
blood
proportion
cell
fewer
b
cell
signific
studi
subject
limit
techniqu
yet
possibl
determin
percentag
b
cell
normal
csf
percentag
b
cell
peripher
blood
welldocu
decreas
rel
absolut
number
cell
blood
ms
patient
report
sever
group
result
howev
show
correl
clinic
activ
diseas
total
cell
estim
erosett
assay
use
sheep
erythrocyt
allen
cowork
increas
activ
sensit
lymphocyt
b
cell
may
induc
exposur
suitabl
antigen
find
suggest
cellular
immun
reactiv
bp
occur
cn
ms
relat
clinic
activ
diseas
lisak
zweimau
measur
lymphocyt
reactiv
bp
incorpor
label
thymidin
incub
cell
data
stimul
peripher
blood
lymphocyt
compar
csflymphocyt
tabl
possibl
correct
variabl
respons
lymphocyt
bp
increas
thymidin
uptak
occur
repeatedli
csf
lymphocyt
cultur
bp
time
blood
lymphocyt
nonreact
antigen
vitro
contrast
pattern
reactiv
seen
commonli
cell
obtain
close
time
acut
exacerb
lesser
extent
progress
stage
diseas
remiss
period
increas
uptak
thymidin
untreat
csf
lymphocyt
suggest
possibl
vivo
stimulatori
effect
cours
diseas
reactiv
lymphocyt
might
account
endogen
stimul
longsurviv
lymphocyt
reflect
entri
monocyt
blood
interest
therefor
although
ms
peripher
blood
lymphocyt
show
littl
vari
respons
stimul
bp
report
stimul
solubl
antigen
ms
brain
give
clearer
differ
rosett
test
activ
cell
develop
refin
techniqu
distinct
progress
de
identif
like
particip
immunolog
respons
ms
although
specif
antibodi
csf
cn
known
antioligodendrogli
antibodi
present
circul
addit
increas
cell
activ
seen
csf
eae
may
relat
delay
hypersensit
reaction
unlik
eae
sensit
may
sole
mediat
myelin
bp
compon
inflammatori
reaction
identifi
relaps
thu
small
definit
chang
total
pml
neutral
proteinas
activ
evid
releas
lysozym
csf
ms
patient
sinc
experiment
allerg
encephalomyel
eke
cellmedi
autoimmun
diseas
use
use
model
discoveri
evalu
immunosuppress
drug
certain
similar
eae
multipl
sclerosi
ms
levin
sowinski
suggest
respons
eae
anim
drug
may
serv
guid
clinic
drug
therapi
perhap
inadequ
guid
better
none
immunosuppress
tabl
tri
mean
interf
develop
express
immun
respons
eae
cytotox
drug
methotrex
folic
acid
antagonist
cyclophosphamid
alkyl
agent
suppress
eae
guinea
pig
cytotox
drug
act
primarili
prolif
phase
lymphocyt
contact
antigen
also
moder
blast
reaction
target
tissu
also
involv
burst
metabol
activ
activ
protein
synthesi
effect
acth
corticosteroid
eha
also
subject
consider
studi
moyer
cowork
found
mg
acth
given
daili
day
inocul
lhth
day
suppress
clinic
sign
diseas
guinea
pig
confirm
speci
administr
agent
delay
week
sensit
adjuv
brain
antigen
onset
neurolog
sign
suppress
diseas
note
kabat
cowork
therefor
suggest
variou
agent
inhibit
inflammatori
reaction
adjuv
local
inject
site
drain
lymph
node
reaction
essenti
product
diseas
suggest
act
corticosteroid
effect
basic
immun
process
within
reticuloendotheli
system
diseas
process
initi
within
central
nervou
system
cn
howev
eae
rabbit
suppress
appropri
larg
dose
methylprednisolon
treatment
delay
within
day
less
time
onset
diseas
control
anim
even
experiment
evid
clinic
improv
anim
treat
onset
eae
suppress
effect
continu
long
drug
discontinu
probabl
due
persist
antigen
studi
suggest
acth
corticosteroid
effect
eae
basic
mechan
within
reticuloendotheli
system
amd
extent
diseas
process
cn
best
protect
eae
achiev
basic
protein
bp
inject
freund
incomplet
adjuv
anim
time
inocul
antigen
complet
adjuv
parallel
reduct
delayedtyp
cutan
sensit
bp
anim
observ
togeth
import
dose
bp
inject
suggest
underli
mechan
desensit
circul
effector
lymphoid
cell
case
remiss
diseas
effect
bp
freund
incomplet
adjuv
given
initi
diseas
symptom
nonencephalitogen
basic
neural
protein
similar
desensit
effect
modifi
nonencephalitogen
myelin
protein
peptid
fragment
lo
peptid
fragment
lack
tryptophan
produc
circul
antibodi
delayedtyp
skin
hypersensit
bp
protect
guinea
pig
eae
arnon
cowork
use
copolym
amino
acid
eg
alanin
glutam
acid
lysin
tyrosin
obtain
protect
eae
guinea
pig
monkey
possibl
bp
may
serv
desensit
patient
ms
examin
year
ago
convinc
success
howev
advers
reaction
observ
low
dose
use
new
initi
studi
effect
larg
dose
mg
per
day
intraderm
inect
sever
centr
role
polnmsatur
fatti
acid
suggest
defici
brain
polyunsatur
fatti
acid
pufa
may
alter
membran
composit
increas
suscept
diseas
clausen
show
diet
defici
linol
acid
essenti
fatti
acid
potenti
action
inject
brain
homogen
produc
eae
rat
later
confirm
selivonchick
johnston
lh
also
show
linol
protect
effect
fed
fatdefici
rat
anim
fatdefici
birth
therefor
much
sever
defici
brain
serum
pufa
found
ms
tissu
sinc
pufa
product
eg
prostaglandin
may
modifi
immunolog
respons
linol
supplement
mlday
fed
guinea
pig
day
sensit
adjuv
bp
period
signific
increas
serum
linol
acid
concentr
chang
brain
fatti
acid
composit
treatment
linol
acid
mild
protect
effect
immedi
time
clinic
sign
normal
appear
fig
oleic
acid
use
control
also
signific
protect
action
increas
oleic
acid
concentr
may
modifi
linol
level
serum
would
account
biolog
activ
linol
supplement
given
day
day
inocul
bp
ceas
week
expect
appear
clinic
sign
signific
protect
suggest
linol
acid
effect
shortliv
regimen
effect
suppress
eae
brought
suppress
vitro
immun
respons
bp
howev
mead
cowork
fail
correl
vitro
lymphocyt
reactiv
bp
treat
anim
degre
clinic
sign
linol
acid
shown
weak
protect
action
graft
reection
suppress
lymphocyt
function
vitro
one
possibl
increas
amount
prostaglandin
e
seri
form
linol
acid
prostaglandin
pronounc
immunosuppress
activ
variou
nonsteroid
antiinfla
natori
drug
test
abil
protect
brain
damag
eae
salicyl
aspirin
found
protect
action
sever
prostaglandin
synthetas
inhibitor
found
ineffect
exampl
flumizol
methoxyphenyl
trifluoromethyl
imidazol
nonacid
trisubstitut
imidazol
penetr
cn
five
time
potent
indomethacin
vivo
carageenaninduc
rat
oedema
test
power
prostaglandin
synthetas
inhibitor
nevertheless
compound
inact
given
day
encephalitogen
may
even
increas
sever
clinic
sign
tabl
suggest
drug
effect
inject
cfa
inject
orbp
vitamin
loss
linol
acid
fed
snimal
compar
untreat
anim
water
fed
anim
paraffin
fed
anim
q
oleic
acid
fed
anim
bar
indic
period
treatment
fmead
cowork
reproduc
permiss
j
neurol
sci
sinc
essenti
fatti
acid
prostaglandin
precursor
mertin
stackpool
examin
effect
combin
supplementari
feed
eae
anim
linol
acid
indomethacin
experi
fatti
acid
supplement
mgkg
daili
significantli
suppress
onset
sever
eae
indomethacin
presum
act
inhibitor
prostaglandin
biosynthesi
abrog
therapeut
effect
unsatur
fatti
acid
experi
guinea
pig
standard
dose
spinal
cord
adjuv
antiinflammatori
drug
found
intensifi
histolog
damag
clinic
sign
diseas
relat
activ
prostaglandin
synthetas
inhibitor
thu
acut
experiment
anim
appear
prostaglandin
may
exert
protect
effect
perhap
mechan
suggest
morley
levin
sowinski
examin
action
hydroxyphthalaldehyd
acid
pchlorobenzyl
oxim
new
oxim
deriv
salicyl
acid
suppress
eae
lewi
rat
acut
hyperacut
eae
respond
protect
effect
drug
tabl
high
dose
mgkg
given
oral
three
time
week
time
inocul
complet
protect
neurolog
sign
smaller
dose
mgkg
sign
develop
day
rather
day
untreat
group
experi
adrenalectom
rat
exclud
possibl
suppress
effect
adrenalmedi
singledos
experi
rat
appear
drug
antigen
guinea
pi
spinal
cord
elevin
sowinski
j
greatest
effect
given
day
encephalitogen
onset
lesion
mortal
affect
drug
given
day
thu
greatest
impact
stage
immedi
histolog
sign
damag
first
occur
ie
day
hand
salicyl
mg
salicylatekg
sc
mgkg
calcium
carbaspirin
mouth
protect
action
given
day
immun
although
substanc
give
protect
treatment
begin
earlier
passiv
transfer
experi
suggest
drug
prevent
even
revers
sensit
neural
antigen
donor
rat
day
inocul
slight
effect
fulli
sensit
lymphoid
cell
recruit
nonimmun
inflammatori
cell
nervou
system
recipi
rat
treat
rel
littl
protect
lesion
score
compar
untreat
anim
addit
pretreat
recipi
lewi
rat
cyclophosphosphamid
inhibit
transfer
eae
sensit
donor
lymph
node
cell
antischistosomiasi
drug
niridazol
recent
found
inhibit
cell
activ
select
sera
guinea
pig
given
drug
ie
contain
metabolit
block
revers
product
antigeninduc
migrat
inhibitori
factor
mif
sensit
guinea
pig
lymph
node
niridazol
loo
mgkg
bodi
weight
given
oral
reduc
clinic
sign
histolog
damag
produc
eae
mice
tabl
drug
effect
treatment
begun
inocul
antigen
protect
last
week
howev
treat
mice
effect
niridazol
either
releas
mif
respons
bp
product
antibodi
nonspeciflc
inflammatori
reaction
adjuv
small
peptid
fungu
metabolit
cyclosporin
appear
act
select
cell
low
cytotox
haemopoietlc
tissu
experi
kidney
cardiac
allograft
suggest
peptid
may
abl
elimin
lymphocyt
clone
respondrd
specif
antigen
challeng
leav
intact
clone
respond
challeng
viru
infect
incid
paralysi
suscept
rat
inocul
spinal
cord
plu
adjuv
ignificantli
reduc
oral
dose
mg
cyclosporin
given
daili
desensit
eke
achiev
pretreat
myelin
bp
immunosuppress
antimetabolit
eg
cyclophosphamid
inhibitor
lymphocyt
protein
synthesi
found
effect
increas
time
onset
sever
clinic
sign
diseas
also
seem
enhanc
synthesi
prostaglandin
may
serv
protect
anim
pufa
supplement
modifi
prostaglandin
synthetas
inhibitor
exagger
paralyt
histolog
effect
may
explain
slight
improv
seen
ms
patient
take
linol
acid
epidemiolog
evid
morpholog
observ
suggest
infect
agent
acquir
childhood
respons
multipl
sclerosi
ms
clue
natur
infect
agent
could
come
specif
studi
antibodi
found
cerebrospin
fluid
csf
patient
igg
isol
affect
postmortem
brain
seem
possibl
agent
may
one
virus
possibl
paramyxoviru
group
far
small
proport
oligoclon
band
found
direct
measl
virus
type
antigen
may
respons
littl
antibodi
myelin
basic
protein
detect
though
circul
antibodi
oligodendrogli
cell
jn
blood
relaps
ms
report
astrocyt
respons
appar
unaffect
part
white
matter
earliest
biochem
chang
presumpt
lesion
increas
lysosom
activ
loss
myelin
bp
bp
highli
sensit
proteolyt
attack
fragment
releas
cerebrospin
fluid
csf
time
exacerb
antigen
activ
residu
may
serv
sensit
peripher
lymphocyt
altern
function
immunoregul
bp
sequenc
homolog
fibroblast
growth
factor
thu
bp
fragment
may
also
respons
activ
astrocyt
region
plaqu
relaps
serum
ms
patient
contain
unidentifi
complementdepend
antibodi
shown
vitro
neuroelectr
block
activ
factor
may
respons
revers
sign
seen
cours
diseas
mani
ms
suffer
possess
characterist
tissu
antigen
type
possibl
associ
differ
natur
immun
respons
individu
compar
unaffect
control
thu
ms
patient
appar
defect
delay
hypersensit
reaction
inde
chang
kappa
lambda
ratio
csf
antibodi
may
also
indic
defect
immunolog
regulatori
mechan
increas
neutral
proteinas
activ
polymorphonuclear
leucocyt
blood
attack
ms
probabl
relat
infla
natori
reaction
frequent
found
around
blood
vessel
demyelin
central
nervou
system
concomit
appear
csf
cell
bound
neutral
proteinas
activ
releas
lysozym
cellular
inun
respons
seem
particularli
import
sensit
cell
found
rais
concentr
csf
ms
patient
close
relaps
find
delay
hypersensit
reaction
drawn
attent
relev
experiment
allerg
encephalomyel
eae
model
inflammatori
reaction
compon
ms
find
relaps
remit
type
chronic
eae
add
signific
experiment
tool
nevertheless
import
differencesfor
exampl
noninvolv
myelin
bp
induct
initi
lesion
ms
rel
lack
demyelin
acut
eae
chronic
condit
also
intrigu
evid
clinic
sign
acut
eae
dissoci
presenc
absenc
neuropatholog
lesion
tabl
although
inflammatori
reaction
one
factor
pathogenesi
ms
perivascular
cuf
invari
associ
demyelin
lesion
may
possibl
allevi
relaps
use
drug
prove
effect
suppress
eae
apart
immunosuppress
alreadi
test
clinic
trial
new
antiinflammatori
drug
act
differ
point
inflammatori
reaction
substanc
eg
prostaglandin
synthetas
inhlbitor
may
actual
increas
diseas
activ
other
exampl
select
act
tlymphocyt
substanc
stimul
prostaglandin
synthesi
may
prove
valu
unfortl
unlik
treatment
would
effect
chronic
ms
case
degen
chang
alreadi
predomin
